Mobix Labs (MOBX) S-1 12 Aug 24 IPO registration Financial data

Document And Entity Information

Document And Entity Information	6 Months Ended
	Mar. 31, 2024
Document Information Line Items
Entity Registrant Name	MOBIX LABS, INC.
Document Type	S-1
Amendment Flag	false
Entity Central Index Key	0001855467
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Incorporation, State or Country Code	DE

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Current assets
Cash	$ 2,993	$ 89
Accounts receivable, net	461	53
Inventory	361	319
Prepaid expenses and other current assets	633	369
Total current assets	4,448	830
Property and equipment, net	1,763	1,859
Intangible assets, net	11,151	5,287
Goodwill	10,759	5,217
Operating lease right-of-use assets	946	1,030
Deferred transaction costs		4,125
Other assets	430	400
Total assets	29,497	18,748
Current liabilities
Accounts payable	6,693	8,995
Accrued expenses and other current liabilities	7,036	4,519
Deferred purchase consideration	803
Notes payable	400	1,286
Simple agreements for future equity (“SAFEs”)		1,512
Operating lease liabilities, current	332	318
Total current liabilities	18,027	20,423
Earnout liability	3,621
PIPE make-whole liability	1,639
Deferred tax liability	176	86
Operating lease liabilities, noncurrent	1,109	1,280
Other noncurrent liabilities	772
Total liabilities	25,344	21,789
Commitments and contingencies (Note 14)
Stockholders’ equity (deficit)
Additional paid-in capital	89,394	78,421
Accumulated deficit	(85,241)	(83,762)
Total stockholders’ equity (deficit)	4,153	(5,341)
Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit)	29,497	18,748
Related Party
Current liabilities
Notes payable – related parties	2,763	3,793
Founders Convertible Preferred Stock
Redeemable convertible preferred stock
Convertible Preferred Stock
Series A Convertible Preferred Stock
Redeemable convertible preferred stock
Convertible Preferred Stock		2,300
Legacy Mobix Common Stock
Stockholders’ equity (deficit)
Common stock, value
Class A Common Stock
Stockholders’ equity (deficit)
Common stock, value
Class B Common Stock
Stockholders’ equity (deficit)
Common stock, value

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Founders Convertible Preferred Stock
Convertible Preferred Stock, par value (in Dollars per share)	$ 0.00001	$ 0.00001
Convertible Preferred Stock, shares authorized		600,000
Convertible Preferred Stock, shares issued		588,235
Convertible Preferred Stock, shares outstanding		588,235
Series A Convertible Preferred Stock
Convertible Preferred Stock, par value (in Dollars per share)	$ 0.00001	$ 0.00001
Convertible Preferred Stock, shares authorized		2,000,000
Convertible Preferred Stock, shares issued		1,666,666
Convertible Preferred Stock, shares outstanding		1,666,666
Convertible Preferred Stock, liquidation preference (in Dollars)		$ 2,300
Legacy Mobix Common Stock
Common stock, par value (in Dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized		57,400,000
Common stock, shares issued		16,692,175
Common stock, shares outstanding		16,692,175
Class A Common Stock
Common stock, par value (in Dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized	285,000,000	285,000,000
Common stock, shares issued	23,600,558
Common stock, shares outstanding	23,600,558
Class B Common Stock
Common stock, par value (in Dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized	5,000,000	5,000,000
Common stock, shares issued	2,254,901
Common stock, shares outstanding	2,254,901

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Net revenue
Product sales	$ 1,145	$ 32	$ 1,430	$ 711
Costs and expenses
Cost of revenue	952	209	1,281	903
Research and development	1,397	2,633	2,959	6,050
Selling, general and administrative	7,358	9,029	23,021	14,823
Loss from operations	(8,562)	(11,839)	(25,831)	(21,065)
Interest expense	248	794	1,105	877
Change in fair value of earnout liability	(5,174)		(29,938)
Change in fair value of PIPE make-whole liability	(3,336)		(432)
Change in fair value of private warrants	420		480
Change in fair value of SAFEs		508	10	558
Merger-related transaction costs expensed			4,009
Other non-operating losses, net	1,049		1,049
Loss before income taxes	(1,769)	(13,141)	(2,114)	(22,500)
Provision (benefit) for income taxes	(16)	1	(1,296)	32
Net loss and comprehensive loss	(1,753)	(13,142)	(818)	(22,532)
Deemed dividend from warrant price adjustment	661		661
Net loss available to common stockholders	$ (2,414)	$ (13,142)	$ (1,479)	$ (22,532)
Net loss per common share:
Basic (in Dollars per share)	$ (0.09)	$ (0.94)	$ (0.06)	$ (1.71)
Diluted (in Dollars per share)	$ (0.21)	$ (0.94)	$ (0.1)	$ (1.71)
Weighted-average common shares outstanding:
Basic (in Shares)	28,045,995	14,025,304	24,259,035	13,189,879
Diluted (in Shares)	29,199,253	14,025,304	24,914,569	13,189,879

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Preferred Stock Founders Redeemable Convertible	Preferred Stock Series A Redeemable Convertible	Contingently Redeemable Common Stock	Legacy Common Stock	Common Stock Class A	Common Stock Class B	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Sep. 30, 2022		$ 2,300					$ 34,722	$ (44,141)	$ (9,419)
Balance (in Shares) at Sep. 30, 2022	588,235	1,666,666		11,868,397
Issuance of common stock							5,295		5,295
Issuance of common stock (in Shares)				773,889
Stock-based compensation							3,856		3,856
Issuance of common stock upon exercise of warrants							900		900
Issuance of common stock upon exercise of warrants (in Shares)				300,000
Net income (Loss)								(9,390)	(9,390)
Balance at Dec. 31, 2022		$ 2,300					44,773	(53,531)	(8,758)
Balance (in Shares) at Dec. 31, 2022	588,235	1,666,666		12,942,286
Balance at Sep. 30, 2022		$ 2,300					34,722	(44,141)	(9,419)
Balance (in Shares) at Sep. 30, 2022	588,235	1,666,666		11,868,397
Net income (Loss)									(22,532)
Balance at Mar. 31, 2023		$ 2,300					61,508	(66,673)	(5,165)
Balance (in Shares) at Mar. 31, 2023	588,235	1,666,666		14,424,203
Balance at Dec. 31, 2022		$ 2,300					44,773	(53,531)	(8,758)
Balance (in Shares) at Dec. 31, 2022	588,235	1,666,666		12,942,286
Issuance of common stock							1,500		1,500
Issuance of common stock (in Shares)				219,475
Issuance of common stock in settlement of loss contingency							8,434		8,434
Issuance of common stock in settlement of loss contingency (in Shares)				1,233,108
Issuance of common stock to service providers							201		201
Issuance of common stock to service providers (in Shares)				29,334
Issuance of warrants to service providers							10		10
Issuance of warrants in connection with notes payable							811		811
Stock-based compensation							5,779		5,779
Net income (Loss)								(13,142)	(13,142)
Balance at Mar. 31, 2023		$ 2,300					61,508	(66,673)	(5,165)
Balance (in Shares) at Mar. 31, 2023	588,235	1,666,666		14,424,203
Balance at Sep. 30, 2023		$ 2,300					78,421	(83,762)	(5,341)
Balance (in Shares) at Sep. 30, 2023	588,235	1,666,666		16,692,175
Issuance of common stock							3,286		3,286
Issuance of common stock (in Shares)				482,171
Issuance of contingently redeemable common stock for acquisition of EMI Solutions, Inc.			$ 8,856
Issuance of contingently redeemable common stock for acquisition of EMI Solutions, Inc. (in Shares)			964,912
Lapse of redemption feature on common stock			$ (8,856)				8,856		8,856
Lapse of redemption feature on common stock (in Shares)			(964,912)	964,912
Issuance of warrants in connection with notes payable							107		107
Stock-based compensation							12,705		12,705
Reverse recapitalization transactions, net (Note 3)		$ (2,300)					(16,182)		(16,182)
Reverse recapitalization transactions, net (Note 3) (in Shares)	(588,235)	(1,666,666)		(18,139,258)	22,901,838	2,254,901
Issuance of common stock upon exercise of stock options
Issuance of common stock upon exercise of stock options (in Shares)					168,235
Issuance of common stock upon exercise of warrants
Issuance of common stock upon exercise of warrants (in Shares)					369,671
Issuance of common stock upon vesting of RSUs
Issuance of common stock upon vesting of RSUs (in Shares)					104,748
Net income (Loss)								935	935
Balance at Dec. 31, 2023							87,193	(82,827)	4,366
Balance (in Shares) at Dec. 31, 2023					23,544,492	2,254,901
Balance at Sep. 30, 2023		$ 2,300					78,421	(83,762)	(5,341)
Balance (in Shares) at Sep. 30, 2023	588,235	1,666,666		16,692,175
Net income (Loss)									(818)
Balance at Mar. 31, 2024							89,394	(85,241)	4,153
Balance (in Shares) at Mar. 31, 2024					23,600,558	2,254,901
Balance at Dec. 31, 2023							87,193	(82,827)	4,366
Balance (in Shares) at Dec. 31, 2023					23,544,492	2,254,901
Stock-based compensation							1,441		1,441
Reverse recapitalization transactions, net (Note 3)							99		99
Issuance of common stock upon exercise of stock options
Issuance of common stock upon exercise of stock options (in Shares)					29,880
Issuance of common stock upon vesting of RSUs
Issuance of common stock upon vesting of RSUs (in Shares)					26,186
Deemed dividend from warrant price adjustment							661	(661)
Net income (Loss)								(1,753)	(1,753)
Balance at Mar. 31, 2024							$ 89,394	$ (85,241)	$ 4,153
Balance (in Shares) at Mar. 31, 2024					23,600,558	2,254,901

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating activities
Net loss	$ (818)	$ (22,532)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	230	225
Amortization of intangible assets	636	421
Issuance of warrants in connection with notes payable, charged to interest expense	884	644
Change in fair value of earnout liability	(29,938)
Change in fair value of PIPE make-whole liability	(432)
Change in fair value of private warrants	480
Change in fair value of SAFEs	10	558
Merger-related transaction costs expensed	4,009
Stock-based compensation	14,146	9,635
Deferred income taxes	(1,296)
Other non-cash items	(536)	29
Changes in operating assets and liabilities, net of acquisition of business:
Accounts receivable	(23)	394
Inventory	113	121
Prepaid expenses and other current assets	(257)	167
Other assets		(293)
Accounts payable	1,358	(553)
Accrued expenses and other current liabilities	(255)	2,474
Net cash used in operating activities	(11,689)	(8,710)
Investing activities
Acquisition of EMI Solutions, Inc., net of cash acquired	(1,110)
Acquisition of property and equipment	(40)	(15)
Net cash used in investing activities	(1,150)	(15)
Financing activities
Proceeds from issuance of common stock	3,286	6,897
Proceeds from exercise of common stock warrants		900
Proceeds from issuance of notes payable	246	1,100
Proceeds from issuance of notes payable – related parties		106
Proceeds from issuance of convertible notes	200	250
Principal payments on notes payable	(1,177)	(350)
Principal payments on notes payable – related parties	(1,030)	(106)
Proceeds from the Merger and PIPE	21,014
Merger-related transaction costs paid	(6,796)	(250)
Net cash provided by financing activities	15,743	8,547
Net increase (decrease) in cash	2,904	(178)
Cash, beginning of period	89	178
Cash, end of period	2,993
Supplemental cash flow information
Cash paid for interest	368
Cash paid for income taxes
Non-cash investing and financing activities:
Unpaid Merger-related transaction costs	1,575	2,745
Contingently redeemable convertible stock issued for acquisition of EMI Solutions, Inc.	8,856
Deferred purchase consideration for acquisition of EMI Solutions, Inc.	886
Conversion of SAFEs to common stock	1,522
Deemed dividend from warrant price adjustment	661
Issuance of warrants in connection with notes payable, recorded as debt discount	107	167
Issuance of common stock to service providers		$ 201

Company Information

Company Information	6 Months Ended
	Mar. 31, 2024
Company Information [Abstract]
Company Information	Note 1 — Company Information Mobix Labs, Inc. (“Mobix Labs” or the “Company”), a Delaware corporation based in Irvine, California, is a fabless semiconductor company developing mmWave 5G and C -Band -quality On December 21, 2023, (the “Closing Date”), Chavant Capital Acquisition Corp. (“Chavant”) consummated the merger pursuant to the Business Combination Agreement, dated November 15, 2022 (as amended, supplemented or otherwise modified, the “Business Combination Agreement”), by and among Chavant, CLAY Merger Sub II, Inc., a Delaware corporation and newly formed, wholly -owned -owned Throughout the notes to the condensed consolidated financial statements, unless otherwise noted or otherwise suggested by context, the “Company” refers to Legacy Mobix prior to the consummation of the Merger, and to the Company after the consummation of the Merger. Going Concern The condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. Since inception, the Company has incurred operating losses and negative cash flows from operations, primarily as a result of its ongoing investment in product development. For the six months ended March 31, 2024 and 2023, the Company incurred losses from operations of $25,831 and $21,065, respectively, and as of March 31, 2024 the Company had an accumulated deficit of $85,241. The Company has historically financed its operations through the issuance and sale of equity securities and the issuance of debt. The Company expects to continue to incur operating losses and negative cash flows from operations for the foreseeable future and will need to raise additional debt or equity financing to fund its operations and satisfy its obligations. While the Company recently entered into a committed equity facility to raise additional capital, the amount and timing of the proceeds, if any, the Company may receive from the sale of shares of Class A Common Stock thereunder will depend on a number of factors, including the numbers of shares the Company may elect to sell, the timing of such sales, the future market price of the Company’s Class A Common stock and the payment of the cash commitment fee (see Note 16 — Equity While the Company will seek to raise additional capital, there can be no assurance the necessary financing will be available on terms acceptable to the Company, or at all. If the Company raises funds by issuing equity securities, dilution to existing stockholders may result. Any equity securities issued may also provide for rights, preferences or privileges senior to those of holders of common stock. If the Company raises funds by issuing debt securities, such debt securities would have rights, preferences and privileges senior to those of preferred and common stockholders. The terms of debt securities or borrowings may impose significant restrictions on the Company’s operations. The capital markets have in the past, and may in the future, experience periods of volatility that could impact the availability and cost of equity and debt financing. In addition, recent and potential future increases in federal fund rates set by the Federal Reserve, which serve as a benchmark for rates on borrowing, could adversely impact the cost or availability of debt financing. If the Company is unable to obtain additional financing, or if such transactions are successfully completed but do not provide adequate financing, the Company may be required to reduce its operating expenditures, which could adversely affect its business prospects, or the Company may be unable to continue operations. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties. Accordingly, the condensed consolidated financial statements have been prepared on a basis that assumes the Company will continue as a going concern and which contemplates the realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Mar. 31, 2024
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 — Summary of Significant Accounting Policies Basis of Presentation The Merger was accounted for as a reverse recapitalization of the Company because Legacy Mobix has been determined to be the accounting acquirer under ASC Topic 805 — Business Combinations The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and include the accounts of Mobix Labs, Inc. and its subsidiaries. The Company’s fiscal year ends on September 30. Certain information and disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. Accordingly, these condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements as of and for the year ended September 30, 2023 and the related notes which provide a more complete discussion of the Company’s accounting policies and certain other information. The September 30, 2023 condensed consolidated balance sheet was derived from the Company’s audited financial statements. These unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for a fair statement of the Company’s condensed consolidated financial position as of March 31, 2024 and its condensed consolidated results of operations and cash flows for the periods ended March 31, 2024 and 2023. The condensed consolidated results of operations for the three months and six months ended March 31, 2024 are not necessarily indicative of the results to be expected for the fiscal year ending September 30, 2024 or for any other future annual or interim period. Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of the Company’s condensed consolidated financial statements requires the Company to make estimates and assumptions that affect the reported amounts of certain assets and liabilities; the reported amounts of revenues and expenses for the periods covered and certain amounts disclosed in the notes to the condensed consolidated financial statements. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could differ materially from those estimates and assumptions. Areas requiring significant estimates and assumptions by the Company include, but are not limited to: • -based -based • • -lived • -whole • • Cash As of March 31, 2024 and September 30, 2023, the Company’s cash balance consisted of demand deposits held at large financial institutions. The Company considers all highly liquid investments with a maturity of three months or less to be cash equivalents. The Company had no cash equivalents as of March 31, 2024 or September 30, 2023. The amount of deposits maintained at any financial institution may exceed federally insured limits. The Company places its cash with high credit quality financial institutions and has not experienced any losses on its deposits of cash. Accounts Receivable, net Accounts receivable are recorded at the invoiced amount and do not bear interest. For trade accounts receivable from customers, the Company performs ongoing credit evaluations of its customers and maintains an allowance for expected credit losses. The allowance for expected credit losses represents the Company’s best estimate based on current and historical information, and reasonable and supportable forecasts of future events and circumstances. Accounts receivable deemed uncollectible are charged against the allowance for expected credit losses when identified. The allowance for expected credit losses as of March 31, 2024 and September 30, 2023 and bad debt expense for the six months ended March 31, 2024 and 2023 were not material. Inventory Inventory is stated at the lower of cost, determined on a first -in -out -downs Intangible Assets, net The Company’s intangible assets principally consist of acquired developed technology and customer relationships and have finite lives ranging from one fifteen -line -related Impairment of Long-Lived Assets The Company reviews its long -lived -lived Goodwill Goodwill represents the excess of the fair value of purchase consideration of an acquired business over the fair value of the identifiable net assets acquired. Goodwill is not amortized but is tested for impairment at a reporting unit level on an annual basis on July 31, or more frequently if circumstances change or an event occurs that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The Company did not record any goodwill impairment losses for the three months and six months ended March 31, 2024 and 2023. Business Combinations The Company allocates the purchase price of an acquisition to the tangible assets acquired, liabilities assumed, and intangible assets acquired, based on their estimated fair values. The excess of the purchase price over the fair values of the net assets acquired is recorded as goodwill. Accounting for business combinations requires that management make significant estimates and assumptions to determine the fair value of assets acquired and liabilities assumed at the acquisition date. Although management believes the assumptions and estimates to be reasonable and appropriate, they are inherently uncertain. Critical estimates in valuing certain acquired assets may include, but are not limited to, expected future cash flows including revenue growth rate assumptions from product sales, customer contracts and acquired technologies, expected costs to develop acquired technology into commercially viable products, estimated cash flows from the projects when completed, including assumptions associated with the technology migration curve and expected selling, general and administrative costs. The discount rates used to discount expected future cash flows to present value are typically derived from a weighted -average Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The Company uses a three -tiered As a basis for considering such assumptions, a three -tier Level 1 — Observable inputs that include quoted prices in active markets for identical assets or liabilities. Level 2 — Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 — Unobservable pricing inputs that are generally less observable from objective sources, such as discounted cash flow models or valuations. Net Income (Loss) Per Share Basic and diluted net income (loss) per share attributable to common stockholders is presented in conformity with the two -class -class -average -average Net Loss Per Share. Comprehensive Loss Comprehensive loss includes the Company’s net loss as well as other changes in stockholders’ equity that result from transactions and economic events other than those with stockholders. There were no differences between the Company’s net loss and comprehensive loss for the three months and six months ended March 31, 2024 and 2023. Accounting Pronouncements Recently Adopted The Company is an “emerging growth company,” as defined in the Securities Act. Under the Jumpstart Our Business Startups Act of 2012, an emerging growth company has the option to adopt new or revised accounting guidance either (i) within the same periods as otherwise applicable to public business entities, or (ii) within the same time periods as non -public -public In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016 -13 Financial Instruments — Credit Losses (Topic 326) -13 In October 2021, the FASB issued ASU 2021 -08 Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers -08 -08 Recently Issued Accounting Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU 2023 -07 Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures -07 -07 -07 -07 In December 2023, the FASB issued ASU 2023 -09 Income Taxes (Topic 740): Improvements to Income Tax Disclosures -09 -09 -09

Reverse Recapitalization

Reverse Recapitalization	6 Months Ended
	Mar. 31, 2024
Reverse Recapitalization [Abstract]
Reverse Recapitalization	Note 3 — Reverse Recapitalization As discussed in Note 1, Company Information • • • • • • The other related events that occurred in connection with the Closing include the following: • • • -redemption • • , Warrants • Equity Incentive Plans • • PIPE Subscription Agreements In connection with the Merger, Chavant entered into the PIPE Subscription Agreements with certain accredited investors and pursuant to which the investors agreed to purchase an aggregate of 1,975,000 Make -Whole Shares The PIPE investors also received warrants to purchase 1,950,000 Sponsor PIPE Subscription Agreements, Sponsor Warrant and Sponsor Letter Agreement On December 19, 2023, Chavant entered into the Sponsor PIPE Subscription Agreement with the Sponsor pursuant to which the Sponsor agreed to purchase, in a private placement that closed substantially concurrently with the Closing, 199,737 Make -Whole Shares In connection with the execution of the Sponsor PIPE Subscription Agreement, Legacy Mobix Labs issued to the Sponsor a warrant to purchase 272,454 On December 20, 2023, Chavant also entered into a Sponsor Letter Agreement with the Sponsor pursuant to which, as consideration for the 199,737 Non-Redemption Agreement On December 20, 2023, Chavant and Mobix Labs entered into a non -redemption Amendment to Business Combination Marketing Agreement On December 21, 2023, Chavant entered into an amendment to the Business Combination Marketing Agreement, dated as of July 19, 2021 between Chavant and certain advisors wherein the parties agreed to resolve their differences with respect to marketing fees contemplated by the agreement and the advisors agreed to receive, in lieu of any cash payment of fees or reimbursement of expenses, an aggregate of 280,000 Make -Whole Shares Earnout Shares In addition to the consideration paid at Closing, certain Legacy Mobix stockholders and certain holders of Legacy Mobix stock options (the “Earnout Recipients”) will be entitled to receive an additional aggregate 3,500,000 -year The Earnout Shares are accounted for as liability -classified -cash Make-Whole Shares Pursuant to the PIPE Subscription Agreements, the Sponsor PIPE Subscription Agreement and the Amendment to Business Combination Marketing Agreement described above, Chavant agreed to issue additional shares of its Class A Common Stock (the “Make -Whole -day -Whole The Make -Whole -classified -Whole -Whole -Whole -cash -whole See Note 12, Fair Value Measurements Legacy Mobix incurred $6,363 of transaction costs in connection with the Merger, which was determined to be a capital -raising -classified -classified -classified -in -classified The following tables reconcile elements of the Merger to the Company’s condensed consolidated financial statements, and should be read in conjunction with the footnotes referenced above: Shares Chavant public shares, net of redemptions 111,005 Chavant founder shares, net of shares forfeited 1,341,369 PIPE investors’ shares 1,975,000 Settlement of PIPE warrant 199,800 Sponsor PIPE subscription 199,737 Settlement of Sponsor Warrant 272,182 Settlement of warrant to non-redeeming shareholder 202,489 Amendment to Business Combination Marketing Agreement 280,000 Total Chavant shares outstanding immediately prior to the Merger 4,581,582 Legacy Mobix rollover shares 18,139,258 Conversion of Legacy Mobix convertible notes 30,045 Conversion of Legacy Mobix SAFEs 150,953 Total number of Class A common shares issued in the Merger 22,901,838 Closing proceeds: Proceeds from Chavant trust fund $ 1,264 Proceeds from PIPE investment 19,750 Closing disbursements: Legacy Mobix Merger-related transaction costs (3,747 ) Chavant Merger-related transaction costs (2,219 ) Net cash proceeds from the Merger at Closing 15,048 Legacy Mobix Merger-related transaction costs paid prior to closing (983 ) Net cash proceeds 14,065 Non-cash activity: Conversion of Legacy Mobix convertible notes to Class A Common Stock 206 Conversion of Legacy Mobix SAFEs to Class A Common Stock 1,522 Conversion of Legacy Mobix redeemable convertible preferred stock to Class B Common Stock 2,300 Unpaid Merger-related transaction costs assumed from Chavant (871 ) Unpaid Merger-related transaction costs of Legacy Mobix (1,633 ) Merger-related transaction costs expensed 4,009 Liability-classified instruments: Fair value of earnout liability (33,559 ) Fair value of PIPE make-whole liability (2,071 ) Fair value of Private Warrants (150 ) Net equity impact of the Merger $ (16,182 ) Subsequent to the Closing, the Company paid $830 of the Merger -related

Warrants

Warrants	6 Months Ended
	Mar. 31, 2024
Warrants [Abstract]
Warrants	Note 4 — Warrants Public and Private Warrants In connection with its initial public offering, Chavant issued 6,000,000 Public Warrants and 3,400,000 Private Warrants (of which 400,000 Private Warrants were subsequently forfeited by the Sponsor), each of which entitles the holder to purchase one share of the Company’s Class A Common Stock at a price of $11.50 per share, subject to adjustments. The Public Warrants and Private Warrants are exercisable at any time commencing thirty days after the completion of the Merger and terminating five years after the completion of the Merger. The Company may redeem the Public Warrants at a price of $0.01 per warrant if the last reported sale of the Company’s Class A Common Stock equals or exceeds $18.00 per share for any twenty trading days within a thirty -day The Private Warrants are identical to the Public Warrants, except that the Private Warrants and shares of Class A Common Stock issuable upon the exercise of the Private Warrants are not transferable, assignable or salable until thirty days after the completion of the Merger, subject to certain limited exceptions. Additionally, the Private Warrants are exercisable on a cashless basis and are non -redeemable Both the Public Warrants and Private Warrants are subject to adjustment if the Company issues additional equity securities for capital raising purposes at price (the “Newly Issued Price”) below specified levels; if the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds available for funding Merger at the Closing; and, if the VWAP of the Company’s Class A Common Stock during a specified period (“Market Value”) is below $9.20 per share. In such event, the exercise price of the warrants will be adjusted to be equal to 115% of the Market Value and the $18.00 per share redemption trigger price will be adjusted to be equal to 180% of the Newly Issued Price. As a result of the issuances of shares under the PIPE Subscription Agreement and other agreements in connection with the Merger, the Company adjusted the exercise price of the warrants from $11.50 to $5.79 per share and adjusted the redemption trigger price from $18.00 to $9.06 per share. The Company recognized a noncash deemed dividend of $661 as a result of the warrant price adjustment. Upon the Closing, the Company concluded that the Public Warrants meet the derivative scope exception for contracts in the Company’s own stock and recorded the Public Warrants in stockholders’ equity. The Company concluded that the Private Warrants do not meet the derivative scope exception and are accounted for as liabilities. Specifically, the Private Warrants contain provisions that affect the settlement amounts dependent upon the characteristics of the holder of the warrant, which is not an input into the pricing of a fixed -for-fixed -Scholes -pricing -cash PIPE Warrants In connection with the PIPE Subscription Agreements, the Company issued the investors warrants to purchase shares of common stock at an exercise price of $0.01 per share. The Company evaluated these warrants and concluded that they meet the derivative scope exception for contracts in the Company’s own stock. Consequently, the PIPE warrants were recorded in stockholders’ equity. Legacy Mobix Warrants In connection with the Merger, all of Legacy Mobix’s outstanding warrants were assumed by the Company and converted into the same number of warrants to purchase shares of the Company’s Class A Common Stock, with no change to their exercise prices or other terms. Subsequent to the Merger, warrants to purchase an aggregate of 373,031 During the six months ended March 31, 2024, Legacy Mobix issued warrants to purchase an aggregate of 51,020 Debt Also during the six months ended March 31, 2024, Legacy Mobix granted warrants to purchase an aggregate of 27,413 Equity As of March 31, 2024, the Company is obligated to issue warrants to purchase 130,000 Debt -operating -weighted During the six months ended March 31, 2023, the Company issued warrants to purchase an aggregate of 300,000 -service See Note 12, Fair Value Measurements

Acquisition of EMI Solutions, I

Acquisition of EMI Solutions, Inc.	6 Months Ended
	Mar. 31, 2024
Acquisition of EMI Solutions, Inc. [Abstract]
Acquisition of EMI Solutions, Inc.	Note 5 — Acquisition of EMI Solutions, Inc. On December 18, 2023, the Company completed the acquisition of EMI Solutions when the Company acquired all of the issued and outstanding common shares of EMI Solutions, which is accounted for as a business combination. EMI Solutions is a manufacturer of electromagnetic interference filtering products for military and aerospace applications. The Company believes the acquisition of EMI Solutions will complement its existing product offerings, expand its customer base and allow it to deliver solutions that address a wider variety of applications and markets. Consideration for the acquisition consisted of 964,912 The merger agreement with EMI Solutions provided that in the event that Legacy Mobix did not complete an initial public offering (including the Merger) within twenty -four -Scholes no -free The following table summarizes the amount of the aggregate purchase consideration and the preliminary allocation to the tangible and identifiable intangible assets acquired and liabilities assumed based on their estimated fair values, of which the valuation of intangible assets is subject to finalization: Purchase consideration: Contingently redeemable common stock issued to seller $ 8,856 Cash consideration (at present value) 2,041 $ 10,897 Allocation: Cash $ 45 Accounts receivable 387 Inventory 155 Other current assets 7 Property and equipment 107 Other assets 30 Intangible asset – customer relationships 6,100 Intangible asset – backlog 300 Intangible asset – trade name 100 Goodwill 5,542 Accounts payable (227 ) Accrued expenses (263 ) Deferred tax liability (1,386 ) $ 10,897 The Company estimated the useful life of customer relationships is fifteen years, the useful life of the trade name is two years and the useful life of the backlog is one year. The goodwill is primarily attributed to expected synergies for the combined operations and is not deductible for income tax purposes. The operating results of EMI Solutions are included in the Company’s condensed consolidated financial statements for periods subsequent to the acquisition date. The amounts of revenues and net loss of EMI Solutions included in the Company’s condensed consolidated statement of operations and comprehensive loss for the six months ended March 31, 2024 were $997 and $454, respectively. The following table shows unaudited pro forma revenues and net loss of the Company, as if the acquisition of EMI Solutions had been completed as of October 1, 2022. The unaudited pro forma information is presented for informational purposes only and is not necessarily indicative of future operations or results had the acquisition occurred on October 1, 2022. Three months ended Six months ended 2024 2023 2024 2023 Revenues $ 1,145 $ 678 $ 2,197 $ 2,015 Net loss (1,753 ) (13,129 ) (733 ) (22,692 )

Inventory

Inventory	6 Months Ended
	Mar. 31, 2024
Inventory [Abstract]
Inventory	Note 6 — Inventory Inventory consists of the following: March 31, September 30, Raw materials $ 183 $ 265 Finished goods 178 54 Total inventory $ 361 $ 319

Property and Equipment, Net

Property and Equipment, Net	6 Months Ended
	Mar. 31, 2024
Property and Equipment, Net [Abstract]
Property and Equipment, net	Note 7 — Property and Equipment, net Property and equipment, net consists of the following: Estimated Useful Life March 31, September 30, Equipment and furniture 5 – 7 $ 924 $ 858 Laboratory equipment 5 621 601 Leasehold improvements Shorter of estimated useful life or remaining lease term 891 850 Construction in progress 584 584 Property and equipment, gross 3,020 2,893 Less: Accumulated depreciation (1,257 ) (1,034 ) Property and equipment, net $ 1,763 $ 1,859 Depreciation expense for the three months ended March 31, 2024 and 2023 was $117 and $112, respectively. Depreciation expense for the six months ended March 31, 2024 and 2023 was $230 and $225, respectively.

Intangible Assets, Net

Intangible Assets, Net	6 Months Ended
	Mar. 31, 2024
Intangible Assets, Net [Abstract]
Intangible Assets, net	Note 8 — Intangible Assets, net Intangible assets, net consist of the following: Estimated March 31, 2024 September 30, 2023 Gross Accumulated Net Gross Accumulated Net Developed technology 7 – 10 $ 7,289 $ (2,644 ) $ 4,645 $ 7,289 $ (2,238 ) $ 5,051 Customer relationships 10 – 15 6,400 (195 ) 6,205 300 (64 ) 236 Trade names 2 100 (14 ) 86 — — — Backlog 1 300 (85 ) 215 — — — $ 14,089 $ (2,938 ) $ 11,151 $ 7,589 $ (2,302 ) $ 5,287 The Company recorded amortization expense related to intangible assets of $399 and $210 during the three months ended March 31, 2024 and 2023, respectively, and $636 and $421 during the six months ended March 31, 2024 and 2023, respectively. The weighted -average nine Estimated future amortization expense for intangible assets by fiscal year as of March 31, 2024 is as follows: Years ending September 30, 2024 (remaining six months) $ 799 2025 1,361 2026 1,258 2027 1,247 2028 1,213 Thereafter 5,273 Total $ 11,151

Goodwill

Goodwill	6 Months Ended
	Mar. 31, 2024
Goodwill [Abstract]
Goodwill	Note 9 — Goodwill The following table summarizes changes in the carrying amount of goodwill during the six months ended March 31, 2024. There were no changes in the carrying amount of goodwill during the six months ended March 31, 2023. Balance at September 30, 2023 $ 5,217 Acquisition of EMI 5,542 Balance at March 31, 2024 $ 10,759

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	6 Months Ended
	Mar. 31, 2024
Accrued Expenses and Other Current Liabilities [Abstract]
Accrued Expenses and Other Current Liabilities	Note 10 — Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consist of the following: March 31, September 30, Accrued compensation and benefits $ 1,765 $ 2,841 Liability-classified warrants 206 — Accrued professional fees 706 273 Accrued interest 132 304 Deferred revenue 43 138 Committed equity facility fees 1,575 — Unpaid Merger-related transaction costs 1,240 — Other 1,369 963 Total accrued expenses and other current liabilities $ 7,036 $ 4,519

Debt

Debt	6 Months Ended
	Mar. 31, 2024
Debt [Abstract]
Debt	Note 11 — Debt Debt consists of the following: March 31, September 30, Notes payable $ 400 $ 1,286 7% promissory notes – related parties 2,763 3,349 Notes payable – related parties — 444 SAFEs — 1,512 Total debt 3,163 6,591 Less: Amounts classified as current (3,163 ) (6,591 ) Noncurrent portion $ — $ — Notes Payable During the six months ended March 31, 2024, the Company entered into two promissory notes payable having an aggregate principal amount of $250 with unrelated investors to meet its working capital needs. The notes bear interest at rates ranging from 6% to 76% per annum. One note having an original principal amount of $150 matures in November 2024, requires weekly principal payments of $4 and is guaranteed by an officer and director of the Company. The other note, having a principal amount of $100, is unsecured, matured in January 2024 and was repaid by the Company in February 2024. In connection with the issuance of one of the notes, the Company issued the purchaser a warrant to purchase an aggregate of 47,020 twelve -in -Scholes no -free twelve One note, issued in September 2023 and having a principal amount of $531, provided that in the event the Company failed to pay the principal amount by its October 5, 2023 maturity date, the Company must issue the purchaser as additional consideration a warrant to purchase 28,000 During the six months ended March 31, 2023, the Company entered into five promissory notes payable having an aggregate principal amount of $1,100 with unrelated investors to meet its working capital needs. The notes matured at various dates through March 2024. During the six months ended March 31, 2023, the Company repaid $350 under one of these notes. In connection with the issuance of the notes, the Company gave the purchasers warrants to purchase an aggregate of 35,464 -day As of March 31, 2024, promissory notes payable having a remaining principal balance of $400 were outstanding and are included in “Notes payable” in the condensed consolidated balance sheet. 7% Promissory Notes — Related Parties The Company has two outstanding promissory notes with related parties which the Company assumed in 2020 as part of an asset acquisition. The promissory notes bear interest at 7% per annum, are unsecured and do not require principal payments prior to the maturity date. The notes had an initial maturity date of August 2022, but were amended in May 2022 to extend their maturity to July 2023. During the six months ended March 31, 2024 the Company made principal payments of $586 on one of the notes and as of March 31, 2024 an aggregate principal amount of $2,763 remains outstanding. The 7% promissory notes are included in “Notes payable — related parties” in the condensed consolidated balance sheet. Notes Payable — Related Parties As of September 30, 2023, two notes payable — related parties having an aggregate principal balance of $444 were outstanding. During the six months ended March 31, 2024, the Company repaid each of the notes in full. During the six months ended March 31, 2023, the Company issued a promissory note having a principal balance of $106 to an employee of the Company, and repaid the note in full. SAFEs In connection with the Merger, all of the outstanding SAFEs, representing an original purchase amount of $1,000, were converted into 150,953 The Company remeasured the SAFEs to fair value at each reporting date. For the six months ended March 31, 2024 and 2023, the Company recorded increases in the fair value of the SAFEs of $10 and $50, respectively. The change in fair value of the SAFEs is reported in “Change in fair value of SAFEs” in the condensed consolidated statements of operations and comprehensive loss. Convertible Notes During the six months ended March 31, 2024, the Company issued convertible notes having an aggregate principal amount of $200 to unaffiliated investors. The convertible notes matured in February 2024, bore interest at 16% per annum, were unsecured and had a conversion price of $6.84 per share. The principal amount of the convertible notes and any accrued interest thereon was convertible into shares of the Company’s common stock, at the election of each holder, at any time prior to maturity. In connection with the issuance of the convertible notes, the Company issued the investors warrants to purchase an aggregate of 4,000 -year

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Mar. 31, 2024
Fair Value Measurements [Abstract]
Fair Value Measurements	Note 12 — Fair Value Measurements The carrying amounts of the Company’s cash, accounts receivable and accounts payable approximate their fair value due to the short -term Fair Value Hierarchy Liabilities measured at fair value on a recurring basis as of March 31, 2024 are as follows: Level 1 Level 2 Level 3 Total Earnout liability $ — $ — $ 3,621 $ 3,621 PIPE make-whole liability — — 1,639 1,639 Private Warrants and other warrants — — 836 836 Total $ — $ — $ 6,096 $ 6,096 The Company classifies the earnout liability, the PIPE make -whole Six months ended March 31, 2024: Earnout PIPE Private SAFEs Balance, September 30, 2023 $ — $ — $ — $ 1,512 Liabilities recognized 33,559 2,071 882 — Conversion to Class A Common Stock in the Merger — — — (1,522 ) Change in fair value included in net loss (29,938 ) (432 ) (46 ) 10 Balance, March 31, 2024 $ 3,621 $ 1,639 $ 836 $ — Six months ended March 31, 2023: SAFEs Balance, September 30, 2022 $ 1,983 Change in fair value included in net loss 558 Balance, March 31, 2023 $ 2,541 Earnout Liability The Company estimates the fair value of the earnout liability using a Monte Carlo simulation model that utilizes significant assumptions, including volatility, expected term and risk -free December 21, March 31, Stock price $ 10.66 $ 2.01 Expected volatility 50 % 60 % Risk-free rate 3.9 % 4.1 % Contractual term 8 years 7.7 years PIPE Make-Whole Liability The Company uses a Monte Carlo simulation model that utilizes significant assumptions, including volatility, expected term and risk -free -whole -whole December 21, March 31, Stock price $ 10.17 $ 1.56 Expected volatility 49 % 51 % Risk-free rate 5.4 % 5.4 % Contractual term 4 months 3 months

Leases

Leases	6 Months Ended
	Mar. 31, 2024
Leases [Abstract]
Leases	Note 13 — Leases The Company has entered into operating leases for office space. The leases have remaining terms ranging from three months to 3.4 years and expire at various dates through August 2027. The leases do not contain residual value guarantees or restrictive covenants. The lease covering the Company’s 19,436 square foot headquarters in Irvine, California provides the Company an option to extend the lease for one additional five -year The following lease costs are included in the condensed consolidated statement of operations and comprehensive loss: Six months ended 2024 2023 Operating lease cost $ 200 $ 202 Short-term lease cost 46 155 Total lease cost $ 246 $ 357 Cash paid for amounts included in the measurement of operating lease liabilities for the six months ended March 31, 2024 and 2023 was $273 and $264, respectively. As of March 31, 2024, the weighted -average -average -of-use The following table reconciles the undiscounted cash flows to the operating lease liabilities recorded on the condensed consolidated balance sheet as of March 31, 2024: Years ending September 30, 2024 (remaining six months) $ 275 2025 526 2026 545 2027 515 Total minimum lease payments 1,861 Less: imputed interest (420 ) Present value of future minimum lease payments 1,441 Less: current obligations under leases (332 ) Long-term lease obligations $ 1,109

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Mar. 31, 2024
Commitments and Contingencies [Abstract]
Commitments and Contingencies	Note 14 — Commitments and Contingencies Noncancelable Purchase Commitments The Company has unconditional purchase commitments for services which extend to various dates through September 2024. Future minimum payments under these unconditional purchase commitments as of March 31, 2024 totaled $615. Loss Contingency In fiscal year 2021, the Company recognized a liability for a contingent loss related to a business acquisition. The Company estimated the amount of the liability at $8,434, which was accrued in the condensed consolidated balance sheet as of September 30, 2022. During the six months ended March 31, 2023, the Company issued 1,233,108 Litigation From time to time, the Company may become subject to legal proceedings, claims and litigation arising in the ordinary course of business. The Company does not believe it is currently a party to any material legal proceedings, nor is the Company aware of any other pending or threatened litigation that the Company believes would have a material adverse effect on the Company’s business, operating results, cash flows or financial condition should such litigation be resolved unfavorably. Indemnifications In the ordinary course of business, the Company often includes standard indemnification provisions in its arrangements with customers, suppliers and vendors. Pursuant to these provisions, the Company may be obligated to indemnify such parties for losses or claims suffered or incurred in connection with its service, breach of representations or covenants, intellectual property infringement or other claims made against such parties. These provisions may limit the time within which an indemnification claim can be made. The Company has not in the past incurred significant expense defending against third party claims, nor has it incurred significant expense under its standard service warranties or arrangements with its customers, suppliers and vendors. Accordingly, the Company has not recognized any liabilities for these indemnification provisions as of March 31, 2024 or September 30, 2023.

Income Taxes

Income Taxes	6 Months Ended
	Mar. 31, 2024
Income Taxes [Abstract]
Income Taxes	Note 15 — Income Taxes The Company recorded a provision (benefit) for income taxes of $(16) and $1 for the three months ended March 31, 2024 and 2023, respectively, and a provision (benefit) for income taxes of $(1,296) and $32 for the six months ended March 31, 2024 and 2023, respectively. The provision (benefit) for income taxes for the three months and six months ended March 31, 2024 and 2023 was calculated using the discrete year -to-date -by-jurisdiction

Equity

Equity	6 Months Ended
	Mar. 31, 2024
Equity [Abstract]
Equity	Note 16 — Equity In connection with the Merger, the Company adopted its amended and restated certificate of incorporation and amended and restated bylaws. The amended and restated certificate of incorporation authorizes the issuance of preferred stock, Class A Common Stock and Class B Common Stock. Common Stock The Company is authorized to issue 285,000,000 During the six months ended March 31, 2024, Legacy Mobix sold 482,171 -in During the six months ended March 31, 2023, the Legacy Mobix sold 993,364 As of March 31, 2024, the number of shares of Class A Common Stock available for issuance under the Company’s amended and restated articles of incorporation were as follows: Authorized number of shares of Class A Common Stock 285,000,000 Class A Common Stock outstanding 23,600,558 Reserve for conversion of Class B Common Stock 2,254,901 Reserve for exercise of the Public Warrants and Private Warrants 9,000,000 Reserve for exercise of other common stock warrants outstanding or issuable 3,320,020 Shares issuable under PIPE make-whole provision 1,052,030 Reserve for earnout shares 3,500,000 Stock options and RSUs outstanding 8,601,088 Awards available for grant under 2023 Equity Incentive Plan 2,290,183 Awards available for grant under 2023 Employee Stock Purchase Plan 858,935 Common stock available for issuance 230,522,285 Preferred Stock In connection with the Merger, all outstanding shares of Legacy Mobix Founders Redeemable Convertible Preferred Stock and Series A Redeemable Convertible Preferred Stock were cancelled and converted into 2,254,901 The amended and restated certificate of incorporation authorizes the Company to issue 10,000,000 The Company has never declared or paid any dividends on any class of its equity securities and does not expect to do so in the near future. Committed Equity Facility On March 18, 2024, the Company entered into a Purchase Agreement (“Purchase Agreement”) and a related Registration Rights Agreement with B. Riley Principal Capital II (“B. Riley”) which provides the Company the right, in its sole discretion, and subject to the satisfaction of the conditions set forth therein, to sell to B. Riley up to 9,500,000 newly issued shares of its Class A Common Stock (subject to certain limitations) from time to time. Any sales of Class A Common Stock pursuant to the Purchase Agreement, and the timing of any sales, are solely at the Company’s option, and the Company is under no obligation to sell any securities to B. Riley. The per share purchase price that B. Riley will pay for shares of Class A Common Stock will be determined by reference to the volume weighted average price of the Class A Common Stock measured over the regular trading session or intraday period of the trading session on Nasdaq on the date of each purchase, in each case as defined in the Purchase Agreement, less a three percent discount. As consideration for B. Riley’s commitment to purchase shares of the Company’s Class A Common Stock, the Company agreed to pay a cash commitment fee in the amount of $1,500. B. Riley will withhold 30% in cash from the total aggregate purchase price until B. Riley has received the entire cash commitment fee. If any portion of the commitment fee remains unpaid on the earlier of the termination of the agreement or December 15, 2024, then the Company must pay B. Riley the remainder of the commitment fee in cash. The Company also agreed to reimburse B. Riley for reasonable legal fees and disbursements in an amount not to exceed $75 upon the execution of the Purchase Agreement and Registration Rights Agreement and $5 per fiscal quarter. In April 2024, the Company filed a registration statement with the Securities and Exchange Commission to register under the Securities Act, the offer and resale by B. Riley of up to 9,500,000 As of March 31, 2024, the Company had not sold any shares under the Purchase Agreement. The amount and timing of the proceeds the Company receives from the sale of shares of Class A Common Stock pursuant to the Purchase Agreement, if any, will depend on a number of factors, including the numbers of shares the Company may elect to sell, the timing of such sales, the future market price of the Company’s Class A Common stock and the payment of the cash commitment fee. The cash commitment and other fees under the Purchase Agreement totaling $1,575 are included in “Other non -operating

Equity Incentive Plans

Equity Incentive Plans	6 Months Ended
	Mar. 31, 2024
Equity Incentive Plans [Abstract]
Equity Incentive Plans	Note 17 — Equity Incentive Plans In connection with the Merger, the Company adopted of 2023 Equity Incentive Plan, which provides for the issuance of stock options, restricted stock awards, RSUs and other stock -based Also in connection with the Merger, the Company adopted the 2023 Employee Stock Purchase Plan to assist eligible employees in acquiring stock ownership in the Company. Under the 2023 Employee Stock Purchase Plan, eligible employees may elect to enroll in the plan, designate a portion of eligible compensation to be withheld by the Company during an offering period, and purchase shares of the Company’s Class A Common Stock at the end of such offering period. The price of the shares purchased shall not be less than 85% of the fair market value of a share on the enrollment date or on the purchase date, whichever is lower. The Company has reserved 858,935 Prior to the Merger, Legacy Mobix had three equity incentive plans which provided for the issuance of stock -based Restricted Stock Units In connection with the Merger, all of Legacy Mobix’s RSUs were assumed by the Company and converted into an RSU covering the same number of shares of the Company’s Class A Common Stock. In November 2022, Legacy Mobix and certain of its officers and key employees agreed to enter into amended RSU agreements relating to an aggregate of 10,000,000 RSUs and in March 2023 and May 2023, Legacy Mobix and certain of its officers and key employees agreed to forfeit the 10,000,000 RSUs. The RSUs to these officers and key employees were replaced with a commitment from the Company, contingent upon closing of the Merger, to issue an aggregate of 5,000,000 RSUs (of which 1,000,000 were modified to common stock warrants upon the holder’s termination of employment) over three years, beginning on the first anniversary of the Closing of the Merger. Because the vesting of these awards was subject to both a service condition and a performance condition (the completion of the Merger), the Company determined that vesting of the awards was not probable and did not recognize any stock -based Upon Closing, the performance condition was satisfied, and vesting of the awards is subject only to a service condition. As a result, the Company is required to recognize the value of these awards over the requisite service period. During the six months ended March 31, 2024, the Company recognized stock -based -up -date -based During the six months ended March 31, 2023, certain employees agreed to forfeit 670,000 RSUs with no current replacement award. As a result, the Company recognized $3,706 of additional stock -based A summary of activity in the Company’s RSUs for the six months ended March 31, 2024 is as follows: Number of Weighted- Outstanding at September 30, 2023 209,494 $ 6.84 Performance-based RSUs 3,999,999 $ 8.65 Vested (130,934 ) $ 6.84 Outstanding at March 31, 2024 4,078,559 $ 8.61 No RSUs vested during the six months ended March 31, 2023. Unrecognized compensation expense related to RSUs was $33,946 as of March 31, 2024 and is expected to be recognized over a weighted -average Stock Options In connection with the Merger, all Legacy Mobix stock options were assumed by the Company and converted into the same number of stock options of the Company, with no change to their exercise prices, vesting conditions or other terms. Stock option activity for the six months ended March 31, 2024 is as follows: Number of Weighted- Weighted- Outstanding at September 30, 2023 5,905,684 $ 4.28 Granted 32,200 $ 6.84 Exercised (474,313 ) $ 5.91 Forfeited (941,042 ) $ 6.53 Outstanding at March 31, 2024 4,522,529 $ 3.66 6.3 Exercisable at March 31, 2024 4,041,704 $ 3.29 6.1 The terms of stock option awards permit a “net share settlement” for exercises of stock options, at the Company’s discretion. Stock options exercised during the six months ended March 31, 2024 include options to purchase an aggregate of 474,313 Unrecognized stock -based -average The weighted -average Six months ended March 31, 2024 2023 Range Range Low High Low High Expected volatility 54.8 % 55.6 % 52.4 % 53.6 % Expected dividend yield 0 % 0 % 0 % 0 % Risk-free interest rate 3.9 % 4.4 % 3.6 % 4.2 % Expected term (years) 4.5 5.3 5.0 5.8 The condensed consolidated statements of operations and comprehensive loss include stock -based Three months ended Six months ended 2024 2023 2024 2023 Cost of revenue $ — $ 11 $ — $ 22 Research and development 274 541 775 1,083 Selling, general and administrative 1,167 5,227 13,371 8,530 Total stock-based compensation expense $ 1,441 $ 5,779 $ 14,146 $ 9,635

Net Loss Per Share

Net Loss Per Share	6 Months Ended
	Mar. 31, 2024
Net Loss Per Share [Abstract]
Net Loss Per Share	Note 18 — Net Loss Per Share The Company computes net loss per share of Class A and Class B Common Stock using the two -class -average -average -class -converted In periods where the Company has a net loss, most potentially dilutive securities are not included in the computation as their impact is anti -dilutive -whole -classified those securities. Inclusion of those securities under the if -converted Three months ended 2024 2023 Class A Class B Common Stock Basic net loss per share: Numerator: Allocation of net loss $ (1,612 ) $ (141 ) $ (13,142 ) Deemed dividend from warrant price adjustment (608 ) (53 ) — Net loss available to common stockholders (2,220 ) (194 ) (13,142 ) Denominator: Weighted-average shares outstanding 25,791,094 2,254,901 14,025,304 Basic net loss per share $ (0.09 ) $ (0.09 ) $ (0.94 ) Diluted net loss per share: Numerator: Net loss available to common stockholders $ (2,220 ) $ (194 ) $ (13,142 ) Change in fair value of PIPE make-whole liability (3,068 ) (268 ) — Change in fair value of liability-classified warrants (483 ) (42 ) — Reallocation of net loss as a result of conversion of Class B to Class A Common Stock (504 ) — — Reallocation of net loss — 19 — Allocation of net loss (6,275 ) (485 ) (13,142 ) Denominator: Number of shares used in basic earnings per share calculation 25,791,094 2,254,901 14,025,304 Shares issuable in satisfaction of PIPE make-whole liability 1,052,030 — — Shares issuable under liability-classified warrants 101,228 — — Conversion of Class B to Class A Common Stock 2,254,901 — — Number of shares used in per share computation 29,199,253 2,254,901 14,025,304 Diluted net loss per share $ (0.21 ) $ (0.21 ) $ (0.94 ) Six months ended 2024 2023 Class A Class B Common Stock Basic net loss per share: Numerator: Allocation of net loss $ (742 ) $ (76 ) $ (22,532 ) Deemed dividend from warrant price adjustment (600 ) (61 ) — Net loss available to common stockholders $ (1,342 ) $ (137 ) $ (22,532 ) Denominator: Weighted-average shares outstanding 22,004,134 2,254,901 13,189,879 Basic net loss per share $ (0.06 ) $ (0.06 ) $ (1.71 ) Diluted net loss per share: Numerator: Net loss available to common stockholders $ (1,342 ) $ (137 ) $ (22,532 ) Change in fair value of PIPE make-whole liability (392 ) (40 ) — Change in fair value of liability-classified warrants (476 ) (49 ) — Reallocation of net loss as a result of conversion of Class B to Class A Common Stock (226 ) — — Reallocation of net loss — 6 — Allocation of net loss $ (2,436 ) $ (220 ) $ (22,532 ) Denominator: Number of shares used in basic earnings per share calculation 22,004,134 2,254,901 13,189,879 Shares issuable in satisfaction of PIPE make-whole liability 580,628 Shares issuable under liability-classified warrants 74,906 Conversion of Class B to Class A Common Stock 2,254,901 — — Number of shares used in per share computation 24,914,569 2,254,901 13,189,879 Diluted net loss per share $ (0.10 ) $ (0.10 ) $ (1.71 ) For the purposes of applying the if converted method or treasury stock method for calculating diluted earnings per share, the Public Warrants, Private Warrants, RSUs and stock options result in anti -dilution shares of Class A Common Stock that were excluded from the computation of diluted net income (loss) per share attributable to stockholders for the periods presented because including them would have an antidilutive effect were as follows: Six months ended 2024 2023 Public Warrants and Private Warrants 9,000,000 — Earnout shares 3,500,000 — RSUs 4,078,559 10,984,241 Stock options 4,522,529 6,400,758 Convertible preferred stock (on an as-converted basis) — 2,254,901 Common stock warrants — 400,000 Convertible notes — 131,072 21,101,088 20,170,972

Concentrations

Concentrations	6 Months Ended
	Mar. 31, 2024
Concentrations [Abstract]
Concentrations	Note 19 — Concentrations For the three months ended March 31, 2024, one customer accounted for 26% of the Company’s revenues. For the three months ended March 31, 2023, two customers accounted for 100% of the Company’s revenues. For the six months ended March 31, 2024, three customers accounted for 48% of the Company’s revenues. For the six months ended March 31, 2023, one customer accounted for 82% of the Company’s revenues. No other customer accounted for more than 10% of revenues in the respective periods. As of March 31, 2024, two customers had balances due that represented 48% of the Company’s total accounts receivable. As of September 30, 2023, two customers had balances due that represented 97% of the Company’s total accounts receivable.

Geographical Information

Geographical Information	6 Months Ended
	Mar. 31, 2024
Geographical Information [Abstract]
Geographical Information	Note 20 — Geographical Information Revenues by Geographic Region The Company’s revenues by geographic region, based on ship -to Three months ended Six months ended 2024 2023 2024 2023 United States $ 980 $ 32 $ 1,248 $ 298 Czech Republic — — 17 185 Thailand — — — 225 Other 165 — 165 3 Total net revenue $ 1,145 $ 32 $ 1,430 $ 711 Long-Lived Assets Substantially all of the Company’s long -lived

Subsequent Events

Subsequent Events	6 Months Ended
	Mar. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	Note 21 — Subsequent Events Agreement to Acquire RaGE Systems, Inc. On May 21, 2024, the Company completed the acquisition of RaGE Systems, Inc. (“RaGE Systems”) pursuant to the “RaGE Business Combination Agreement.” RaGE Systems specializes in developing products for 5G communications, mmWave imaging, and software defined radio targeting the commercial, industrial, and defense and aerospace sectors. Aggregate consideration for the acquisition was $12,000 consisting of 3,214,045 -out -back

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	6 Months Ended
	Mar. 31, 2024
Summary of Significant Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The Merger was accounted for as a reverse recapitalization of the Company because Legacy Mobix has been determined to be the accounting acquirer under ASC Topic 805 — Business Combinations The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and include the accounts of Mobix Labs, Inc. and its subsidiaries. The Company’s fiscal year ends on September 30. Certain information and disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. Accordingly, these condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements as of and for the year ended September 30, 2023 and the related notes which provide a more complete discussion of the Company’s accounting policies and certain other information. The September 30, 2023 condensed consolidated balance sheet was derived from the Company’s audited financial statements. These unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for a fair statement of the Company’s condensed consolidated financial position as of March 31, 2024 and its condensed consolidated results of operations and cash flows for the periods ended March 31, 2024 and 2023. The condensed consolidated results of operations for the three months and six months ended March 31, 2024 are not necessarily indicative of the results to be expected for the fiscal year ending September 30, 2024 or for any other future annual or interim period.
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of the Company’s condensed consolidated financial statements requires the Company to make estimates and assumptions that affect the reported amounts of certain assets and liabilities; the reported amounts of revenues and expenses for the periods covered and certain amounts disclosed in the notes to the condensed consolidated financial statements. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could differ materially from those estimates and assumptions. Areas requiring significant estimates and assumptions by the Company include, but are not limited to: • -based -based • • -lived • -whole • •
Cash	Cash As of March 31, 2024 and September 30, 2023, the Company’s cash balance consisted of demand deposits held at large financial institutions. The Company considers all highly liquid investments with a maturity of three months or less to be cash equivalents. The Company had no cash equivalents as of March 31, 2024 or September 30, 2023. The amount of deposits maintained at any financial institution may exceed federally insured limits. The Company places its cash with high credit quality financial institutions and has not experienced any losses on its deposits of cash.
Accounts Receivable, net	Accounts Receivable, net Accounts receivable are recorded at the invoiced amount and do not bear interest. For trade accounts receivable from customers, the Company performs ongoing credit evaluations of its customers and maintains an allowance for expected credit losses. The allowance for expected credit losses represents the Company’s best estimate based on current and historical information, and reasonable and supportable forecasts of future events and circumstances. Accounts receivable deemed uncollectible are charged against the allowance for expected credit losses when identified. The allowance for expected credit losses as of March 31, 2024 and September 30, 2023 and bad debt expense for the six months ended March 31, 2024 and 2023 were not material.
Inventory	Inventory Inventory is stated at the lower of cost, determined on a first -in -out -downs
Intangible Assets, net	Intangible Assets, net The Company’s intangible assets principally consist of acquired developed technology and customer relationships and have finite lives ranging from one fifteen -line -related
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets The Company reviews its long -lived -lived
Goodwill	Goodwill Goodwill represents the excess of the fair value of purchase consideration of an acquired business over the fair value of the identifiable net assets acquired. Goodwill is not amortized but is tested for impairment at a reporting unit level on an annual basis on July 31, or more frequently if circumstances change or an event occurs that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The Company did not record any goodwill impairment losses for the three months and six months ended March 31, 2024 and 2023.
Business Combinations	Business Combinations The Company allocates the purchase price of an acquisition to the tangible assets acquired, liabilities assumed, and intangible assets acquired, based on their estimated fair values. The excess of the purchase price over the fair values of the net assets acquired is recorded as goodwill. Accounting for business combinations requires that management make significant estimates and assumptions to determine the fair value of assets acquired and liabilities assumed at the acquisition date. Although management believes the assumptions and estimates to be reasonable and appropriate, they are inherently uncertain. Critical estimates in valuing certain acquired assets may include, but are not limited to, expected future cash flows including revenue growth rate assumptions from product sales, customer contracts and acquired technologies, expected costs to develop acquired technology into commercially viable products, estimated cash flows from the projects when completed, including assumptions associated with the technology migration curve and expected selling, general and administrative costs. The discount rates used to discount expected future cash flows to present value are typically derived from a weighted -average
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The Company uses a three -tiered As a basis for considering such assumptions, a three -tier Level 1 — Observable inputs that include quoted prices in active markets for identical assets or liabilities. Level 2 — Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 — Unobservable pricing inputs that are generally less observable from objective sources, such as discounted cash flow models or valuations.
Net Income (Loss) Per Share	Net Income (Loss) Per Share Basic and diluted net income (loss) per share attributable to common stockholders is presented in conformity with the two -class -class -average -average Net Loss Per Share.
Comprehensive Loss	Comprehensive Loss Comprehensive loss includes the Company’s net loss as well as other changes in stockholders’ equity that result from transactions and economic events other than those with stockholders. There were no differences between the Company’s net loss and comprehensive loss for the three months and six months ended March 31, 2024 and 2023.
Accounting Pronouncements Recently Adopted	Accounting Pronouncements Recently Adopted The Company is an “emerging growth company,” as defined in the Securities Act. Under the Jumpstart Our Business Startups Act of 2012, an emerging growth company has the option to adopt new or revised accounting guidance either (i) within the same periods as otherwise applicable to public business entities, or (ii) within the same time periods as non -public -public In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016 -13 Financial Instruments — Credit Losses (Topic 326) -13 In October 2021, the FASB issued ASU 2021 -08 Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers -08 -08
Recently Issued Accounting Pronouncements Not Yet Adopted	Recently Issued Accounting Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU 2023 -07 Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures -07 -07 -07 -07 In December 2023, the FASB issued ASU 2023 -09 Income Taxes (Topic 740): Improvements to Income Tax Disclosures -09 -09 -09

Reverse Recapitalization (Table

Reverse Recapitalization (Tables)	6 Months Ended
	Mar. 31, 2024
Reverse Recapitalization [Abstract]
Schedule of Condensed Consolidated Financial Statements	The following tables reconcile elements of the Merger to the Company’s condensed consolidated financial statements, and should be read in conjunction with the footnotes referenced above: Shares Chavant public shares, net of redemptions 111,005 Chavant founder shares, net of shares forfeited 1,341,369 PIPE investors’ shares 1,975,000 Settlement of PIPE warrant 199,800 Sponsor PIPE subscription 199,737 Settlement of Sponsor Warrant 272,182 Settlement of warrant to non-redeeming shareholder 202,489 Amendment to Business Combination Marketing Agreement 280,000 Total Chavant shares outstanding immediately prior to the Merger 4,581,582 Legacy Mobix rollover shares 18,139,258 Conversion of Legacy Mobix convertible notes 30,045 Conversion of Legacy Mobix SAFEs 150,953 Total number of Class A common shares issued in the Merger 22,901,838 Closing proceeds: Proceeds from Chavant trust fund $ 1,264 Proceeds from PIPE investment 19,750 Closing disbursements: Legacy Mobix Merger-related transaction costs (3,747 ) Chavant Merger-related transaction costs (2,219 ) Net cash proceeds from the Merger at Closing 15,048 Legacy Mobix Merger-related transaction costs paid prior to closing (983 ) Net cash proceeds 14,065 Non-cash activity: Conversion of Legacy Mobix convertible notes to Class A Common Stock 206 Conversion of Legacy Mobix SAFEs to Class A Common Stock 1,522 Conversion of Legacy Mobix redeemable convertible preferred stock to Class B Common Stock 2,300 Unpaid Merger-related transaction costs assumed from Chavant (871 ) Unpaid Merger-related transaction costs of Legacy Mobix (1,633 ) Merger-related transaction costs expensed 4,009 Liability-classified instruments: Fair value of earnout liability (33,559 ) Fair value of PIPE make-whole liability (2,071 ) Fair value of Private Warrants (150 ) Net equity impact of the Merger $ (16,182 )

Acquisition of EMI Solutions,_2

Acquisition of EMI Solutions, Inc. (Tables)	6 Months Ended
	Mar. 31, 2024
Acquisition of EMI Solutions, Inc. [Abstract]
Schedule of Purchase Consideration and Allocation	The following table summarizes the amount of the aggregate purchase consideration and the preliminary allocation to the tangible and identifiable intangible assets acquired and liabilities assumed based on their estimated fair values, of which the valuation of intangible assets is subject to finalization: Purchase consideration: Contingently redeemable common stock issued to seller $ 8,856 Cash consideration (at present value) 2,041 $ 10,897 Allocation: Cash $ 45 Accounts receivable 387 Inventory 155 Other current assets 7 Property and equipment 107 Other assets 30 Intangible asset – customer relationships 6,100 Intangible asset – backlog 300 Intangible asset – trade name 100 Goodwill 5,542 Accounts payable (227 ) Accrued expenses (263 ) Deferred tax liability (1,386 ) $ 10,897
Schedule of Unaudited Pro Forma Revenues and Net Loss	The unaudited pro forma information is presented for informational purposes only and is not necessarily indicative of future operations or results had the acquisition occurred on October 1, 2022. Three months ended Six months ended 2024 2023 2024 2023 Revenues $ 1,145 $ 678 $ 2,197 $ 2,015 Net loss (1,753 ) (13,129 ) (733 ) (22,692 )

Inventory (Tables)

Inventory (Tables)	6 Months Ended
	Mar. 31, 2024
Inventory [Abstract]
Schedule of Inventory	Inventory consists of the following: March 31, September 30, Raw materials $ 183 $ 265 Finished goods 178 54 Total inventory $ 361 $ 319

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	6 Months Ended
	Mar. 31, 2024
Property and Equipment, Net [Abstract]
Schedule of Property and Equipment	Property and equipment, net consists of the following: Estimated Useful Life March 31, September 30, Equipment and furniture 5 – 7 $ 924 $ 858 Laboratory equipment 5 621 601 Leasehold improvements Shorter of estimated useful life or remaining lease term 891 850 Construction in progress 584 584 Property and equipment, gross 3,020 2,893 Less: Accumulated depreciation (1,257 ) (1,034 ) Property and equipment, net $ 1,763 $ 1,859

Intangible Assets, Net (Tables)

Intangible Assets, Net (Tables)	6 Months Ended
	Mar. 31, 2024
Intangible Assets, Net [Abstract]
Schedule of Intangible Assets	Intangible assets, net consist of the following: Estimated March 31, 2024 September 30, 2023 Gross Accumulated Net Gross Accumulated Net Developed technology 7 – 10 $ 7,289 $ (2,644 ) $ 4,645 $ 7,289 $ (2,238 ) $ 5,051 Customer relationships 10 – 15 6,400 (195 ) 6,205 300 (64 ) 236 Trade names 2 100 (14 ) 86 — — — Backlog 1 300 (85 ) 215 — — — $ 14,089 $ (2,938 ) $ 11,151 $ 7,589 $ (2,302 ) $ 5,287
Schedule of Estimated Future Amortization Expense for Intangible Assets	Estimated future amortization expense for intangible assets by fiscal year as of March 31, 2024 is as follows: Years ending September 30, 2024 (remaining six months) $ 799 2025 1,361 2026 1,258 2027 1,247 2028 1,213 Thereafter 5,273 Total $ 11,151

Goodwill (Tables)

Goodwill (Tables)	6 Months Ended
	Mar. 31, 2024
Goodwill [Abstract]
Schedule of Goodwill	The following table summarizes changes in the carrying amount of goodwill during the six months ended March 31, 2024. There were no changes in the carrying amount of goodwill during the six months ended March 31, 2023. Balance at September 30, 2023 $ 5,217 Acquisition of EMI 5,542 Balance at March 31, 2024 $ 10,759

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	6 Months Ended
	Mar. 31, 2024
Accrued Expenses and Other Current Liabilities [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consist of the following: March 31, September 30, Accrued compensation and benefits $ 1,765 $ 2,841 Liability-classified warrants 206 — Accrued professional fees 706 273 Accrued interest 132 304 Deferred revenue 43 138 Committed equity facility fees 1,575 — Unpaid Merger-related transaction costs 1,240 — Other 1,369 963 Total accrued expenses and other current liabilities $ 7,036 $ 4,519

Debt (Tables)

Debt (Tables)	6 Months Ended
	Mar. 31, 2024
Debt [Abstract]
Schedule of Debt	Debt consists of the following: March 31, September 30, Notes payable $ 400 $ 1,286 7% promissory notes – related parties 2,763 3,349 Notes payable – related parties — 444 SAFEs — 1,512 Total debt 3,163 6,591 Less: Amounts classified as current (3,163 ) (6,591 ) Noncurrent portion $ — $ —

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Mar. 31, 2024
Fair Value Measurements [Abstract]
Schedule of Liabilities Measured at Fair Value on a Recurring Basis	Liabilities measured at fair value on a recurring basis as of March 31, 2024 are as follows: Level 1 Level 2 Level 3 Total Earnout liability $ — $ — $ 3,621 $ 3,621 PIPE make-whole liability — — 1,639 1,639 Private Warrants and other warrants — — 836 836 Total $ — $ — $ 6,096 $ 6,096
Schedule of Fair Value on a Recurring Basis Using Level 3 Inputs	The following table provides a reconciliation of the balance of financial instruments measured at fair value on a recurring basis using Level 3 inputs: Six months ended March 31, 2024: Earnout PIPE Private SAFEs Balance, September 30, 2023 $ — $ — $ — $ 1,512 Liabilities recognized 33,559 2,071 882 — Conversion to Class A Common Stock in the Merger — — — (1,522 ) Change in fair value included in net loss (29,938 ) (432 ) (46 ) 10 Balance, March 31, 2024 $ 3,621 $ 1,639 $ 836 $ — Six months ended March 31, 2023: SAFEs Balance, September 30, 2022 $ 1,983 Change in fair value included in net loss 558 Balance, March 31, 2023 $ 2,541
Schedule of Assumptions Used in Estimating the Fair Value	The following table summarizes the assumptions used in estimating the fair value of the earnout liability at the respective dates: December 21, March 31, Stock price $ 10.66 $ 2.01 Expected volatility 50 % 60 % Risk-free rate 3.9 % 4.1 % Contractual term 8 years 7.7 years -whole December 21, March 31, Stock price $ 10.17 $ 1.56 Expected volatility 49 % 51 % Risk-free rate 5.4 % 5.4 % Contractual term 4 months 3 months

Leases (Tables)

Leases (Tables)	6 Months Ended
	Mar. 31, 2024
Leases [Abstract]
Schedule of Lease Costs	The following lease costs are included in the condensed consolidated statement of operations and comprehensive loss: Six months ended 2024 2023 Operating lease cost $ 200 $ 202 Short-term lease cost 46 155 Total lease cost $ 246 $ 357
Schedule of Undiscounted Cash Flows to the Operating Lease Liabilities	The following table reconciles the undiscounted cash flows to the operating lease liabilities recorded on the condensed consolidated balance sheet as of March 31, 2024: Years ending September 30, 2024 (remaining six months) $ 275 2025 526 2026 545 2027 515 Total minimum lease payments 1,861 Less: imputed interest (420 ) Present value of future minimum lease payments 1,441 Less: current obligations under leases (332 ) Long-term lease obligations $ 1,109

Equity (Tables)

Equity (Tables)	6 Months Ended
	Mar. 31, 2024
Equity [Abstract]
Schedule of Common Stock Available for Issuance	As of March 31, 2024, the number of shares of Class A Common Stock available for issuance under the Company’s amended and restated articles of incorporation were as follows: Authorized number of shares of Class A Common Stock 285,000,000 Class A Common Stock outstanding 23,600,558 Reserve for conversion of Class B Common Stock 2,254,901 Reserve for exercise of the Public Warrants and Private Warrants 9,000,000 Reserve for exercise of other common stock warrants outstanding or issuable 3,320,020 Shares issuable under PIPE make-whole provision 1,052,030 Reserve for earnout shares 3,500,000 Stock options and RSUs outstanding 8,601,088 Awards available for grant under 2023 Equity Incentive Plan 2,290,183 Awards available for grant under 2023 Employee Stock Purchase Plan 858,935 Common stock available for issuance 230,522,285

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)	6 Months Ended
	Mar. 31, 2024
Equity Incentive Plans [Abstract]
Summary of Activity in the Company's RSUs	A summary of activity in the Company’s RSUs for the six months ended March 31, 2024 is as follows: Number of Weighted- Outstanding at September 30, 2023 209,494 $ 6.84 Performance-based RSUs 3,999,999 $ 8.65 Vested (130,934 ) $ 6.84 Outstanding at March 31, 2024 4,078,559 $ 8.61
Schedule of Stock Option Activity	Stock option activity for the six months ended March 31, 2024 is as follows: Number of Weighted- Weighted- Outstanding at September 30, 2023 5,905,684 $ 4.28 Granted 32,200 $ 6.84 Exercised (474,313 ) $ 5.91 Forfeited (941,042 ) $ 6.53 Outstanding at March 31, 2024 4,522,529 $ 3.66 6.3 Exercisable at March 31, 2024 4,041,704 $ 3.29 6.1
Schedule of Weighted-Average Grant Date Fair Value of Options Granted	The fair value of stock options granted was estimated with the following assumptions: Six months ended March 31, 2024 2023 Range Range Low High Low High Expected volatility 54.8 % 55.6 % 52.4 % 53.6 % Expected dividend yield 0 % 0 % 0 % 0 % Risk-free interest rate 3.9 % 4.4 % 3.6 % 4.2 % Expected term (years) 4.5 5.3 5.0 5.8
Schedule of Consolidated Statements of Operations and Comprehensive Loss Include Stock-Based Compensation Expense	The condensed consolidated statements of operations and comprehensive loss include stock -based Three months ended Six months ended 2024 2023 2024 2023 Cost of revenue $ — $ 11 $ — $ 22 Research and development 274 541 775 1,083 Selling, general and administrative 1,167 5,227 13,371 8,530 Total stock-based compensation expense $ 1,441 $ 5,779 $ 14,146 $ 9,635

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	6 Months Ended
	Mar. 31, 2024
Net Loss Per Share [Abstract]
Schedule of Net Income (Loss) Per Share Per Common Share of Basic and Diluted	those securities. Inclusion of those securities under the if -converted Three months ended 2024 2023 Class A Class B Common Stock Basic net loss per share: Numerator: Allocation of net loss $ (1,612 ) $ (141 ) $ (13,142 ) Deemed dividend from warrant price adjustment (608 ) (53 ) — Net loss available to common stockholders (2,220 ) (194 ) (13,142 ) Denominator: Weighted-average shares outstanding 25,791,094 2,254,901 14,025,304 Basic net loss per share $ (0.09 ) $ (0.09 ) $ (0.94 ) Diluted net loss per share: Numerator: Net loss available to common stockholders $ (2,220 ) $ (194 ) $ (13,142 ) Change in fair value of PIPE make-whole liability (3,068 ) (268 ) — Change in fair value of liability-classified warrants (483 ) (42 ) — Reallocation of net loss as a result of conversion of Class B to Class A Common Stock (504 ) — — Reallocation of net loss — 19 — Allocation of net loss (6,275 ) (485 ) (13,142 ) Denominator: Number of shares used in basic earnings per share calculation 25,791,094 2,254,901 14,025,304 Shares issuable in satisfaction of PIPE make-whole liability 1,052,030 — — Shares issuable under liability-classified warrants 101,228 — — Conversion of Class B to Class A Common Stock 2,254,901 — — Number of shares used in per share computation 29,199,253 2,254,901 14,025,304 Diluted net loss per share $ (0.21 ) $ (0.21 ) $ (0.94 ) Six months ended 2024 2023 Class A Class B Common Stock Basic net loss per share: Numerator: Allocation of net loss $ (742 ) $ (76 ) $ (22,532 ) Deemed dividend from warrant price adjustment (600 ) (61 ) — Net loss available to common stockholders $ (1,342 ) $ (137 ) $ (22,532 ) Denominator: Weighted-average shares outstanding 22,004,134 2,254,901 13,189,879 Basic net loss per share $ (0.06 ) $ (0.06 ) $ (1.71 ) Diluted net loss per share: Numerator: Net loss available to common stockholders $ (1,342 ) $ (137 ) $ (22,532 ) Change in fair value of PIPE make-whole liability (392 ) (40 ) — Change in fair value of liability-classified warrants (476 ) (49 ) — Reallocation of net loss as a result of conversion of Class B to Class A Common Stock (226 ) — — Reallocation of net loss — 6 — Allocation of net loss $ (2,436 ) $ (220 ) $ (22,532 ) Denominator: Number of shares used in basic earnings per share calculation 22,004,134 2,254,901 13,189,879 Shares issuable in satisfaction of PIPE make-whole liability 580,628 Shares issuable under liability-classified warrants 74,906 Conversion of Class B to Class A Common Stock 2,254,901 — — Number of shares used in per share computation 24,914,569 2,254,901 13,189,879 Diluted net loss per share $ (0.10 ) $ (0.10 ) $ (1.71 )
Schedule of Dilutive Securities not Included in Net Income (Loss) Per Share Common Share	Six months ended 2024 2023 Public Warrants and Private Warrants 9,000,000 — Earnout shares 3,500,000 — RSUs 4,078,559 10,984,241 Stock options 4,522,529 6,400,758 Convertible preferred stock (on an as-converted basis) — 2,254,901 Common stock warrants — 400,000 Convertible notes — 131,072 21,101,088 20,170,972

Geographical Information (Table

Geographical Information (Tables)	6 Months Ended
	Mar. 31, 2024
Geographical Information [Abstract]
Schedule of Company’s Revenue by Geographic Region	The Company’s revenues by geographic region, based on ship -to Three months ended Six months ended 2024 2023 2024 2023 United States $ 980 $ 32 $ 1,248 $ 298 Czech Republic — — 17 185 Thailand — — — 225 Other 165 — 165 3 Total net revenue $ 1,145 $ 32 $ 1,430 $ 711

Company Information (Details)

Company Information (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 20, 2023	Sep. 30, 2023
Company Information [Line Items]
Gross proceeds			$ 21,014
Cash held in trust account	$ 1,264		1,264
Private investment in public equity			$ 19,750
Common stock price per share (in Dollars per share)	$ 0.01		$ 0.01		$ 0.01
Incurred losses from operations	$ (8,562)	$ (11,839)	$ (25,831)	$ (21,065)
Accumulated deficit	$ (85,241)		$ (85,241)			$ (83,762)
Class A Common Stock [Member]
Company Information [Line Items]
Common stock price per share (in Dollars per share)	$ 10		$ 10

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Details) - Developed technology [Member]	Mar. 31, 2024
Minimum [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Finite live intangible assets term	1 year
Maximum [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Finite live intangible assets term	15 years

Reverse Recapitalization (Detai

Reverse Recapitalization (Details) - USD ($) $ / shares in Units, $ in Thousands				3 Months Ended	6 Months Ended
	Dec. 21, 2023	Dec. 20, 2023	Dec. 19, 2023	Mar. 31, 2024	Mar. 31, 2024	Mar. 31, 2023	Apr. 30, 2024	Mar. 18, 2024	Sep. 30, 2023
Reverse Recapitalization [Line Items]
Common stock shares outstanding				23,600,558	23,600,558
Converted into common stock		202,489			272,182
Public warrants					6,000,000
Private placement warrants					3,400,000
Price per share (in Dollars per share)		$ 0.01		$ 0.01	$ 0.01
Weighted average price of the shares purchased (in Dollars per share)				$ 10	$ 10
Warrants to purchase shares exercisable					200,000
Purchase price of certain obligations (in Dollars)			$ 1,997
VWAP price (in Dollars per share)					$ 7
Shares issued		199,737						9,500,000
Aggregate outstanding obligations (in Dollars)		$ 1,997
Redemption of ordinary shares		73,706
Purchase of shares		202,692
Non-cash gains (in Dollars)				$ 5,174
Other non-cash gains (in Dollars)				3,336
Transaction costs (in Dollars)				$ 830	$ 830
Equity-classified instruments costs (in Dollars)					2,354
Liability-classified instruments to expense (in Dollars)					4,009
Unpaid transaction cost (in Dollars)					$ 99
PIPE Subscription Agreements [Member]
Reverse Recapitalization [Line Items]
Price per share (in Dollars per share)				$ 0.01	$ 0.01
Warrants to purchase shares exercisable					1,750,000
Sponsor PIPE Subscription Agreement [Member]
Reverse Recapitalization [Line Items]
Warrants to purchase shares exercisable					272,454
VWAP price (in Dollars per share)			$ 10
Founder Shares [Member[
Reverse Recapitalization [Line Items]
Forfeiture of shares		658,631
Private Warrants [Member]
Reverse Recapitalization [Line Items]
Forfeiture of shares		400,000
Earnout Shares [Member]
Reverse Recapitalization [Line Items]
Shares of common stock				1,750,000	1,750,000
Price per share (in Dollars per share)				$ 12.5	$ 12.5
Aggregate shares					3,500,000
Liability in connection with the merger (in Dollars)					$ 33,559
Liability to its estimated fair value (in Dollars)				$ 3,621	3,621
Non-cash gains (in Dollars)					$ 29,938
Make-Whole Shares [Member]
Reverse Recapitalization [Line Items]
VWAP price (in Dollars per share)					$ 7
Per share value (in Dollars per share)				$ 10	$ 10
Liability in connection with the merger (in Dollars)					$ 2,071
Liability to its estimated fair value (in Dollars)				$ 1,639	1,639
Other non-cash gains (in Dollars)					432
Legacy Mobix [Member]
Reverse Recapitalization [Line Items]
Purchase of shares						993,364
Transaction costs (in Dollars)				$ 6,363	6,363
Unpaid transaction costs (in Dollars)					$ 3,090
Class A Common Stock [Member]
Reverse Recapitalization [Line Items]
Shares of common stock				23,600,558	23,600,558
Common stock shares outstanding				23,600,558	23,600,558
Conversion of notes into shares					30,045
Converted into common stock		202,489			150,953
Aggregate shares purchase					1,975,000
Price per share (in Dollars per share)				$ 10	$ 10
Aggregate amount in cash (in Dollars)					$ 19,750
Shares issued							9,500,000
Aggregate shares	280,000
Per share value (in Dollars per share)	$ 10
Class A Common Stock [Member] | PIPE Subscription Agreements [Member]
Reverse Recapitalization [Line Items]
Shares of common stock				1,950,000	1,950,000
Class A Common Stock [Member] | Sponsor PIPE Subscription Agreement [Member]
Reverse Recapitalization [Line Items]
Shares of common stock			199,737
Converted into common stock					272,182
Price per share (in Dollars per share)			$ 10
Class A Common Stock [Member] | Earnout Shares [Member]
Reverse Recapitalization [Line Items]
Price per share (in Dollars per share)				$ 15	$ 15
Additional shares of common stock				1,750,000	1,750,000
Class A Common Stock [Member] | Make-Whole Shares [Member]
Reverse Recapitalization [Line Items]
Shares of common stock				2,454,737	2,454,737
Price per share (in Dollars per share)				$ 10	$ 10
Class A Common Stock [Member] | Legacy Mobix [Member]
Reverse Recapitalization [Line Items]
Shares of common stock				18,139,258	18,139,258
Common stock shares outstanding				18,139,258	18,139,258
Class B Common Stock [Member]
Reverse Recapitalization [Line Items]
Shares of common stock				2,254,901	2,254,901
Common stock shares outstanding				2,254,901	2,254,901

Reverse Recapitalization (Det_2

Reverse Recapitalization (Details) - Schedule of Condensed Consolidated Financial Statements - USD ($) $ in Thousands	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Closing proceeds:
Proceeds from Chavant trust fund	$ 1,264
Proceeds from PIPE investment	19,750
Closing disbursements:
Legacy Mobix Merger-related transaction costs paid prior to closing	(983)
Net cash proceeds	14,065
Non-cash activity:
Conversion of Legacy Mobix convertible notes to Class A Common Stock	206
Conversion of Legacy Mobix SAFEs to Class A Common Stock	1,522
Conversion of Legacy Mobix redeemable convertible preferred stock to Class B Common Stock	2,300
Unpaid Merger-related transaction costs assumed from Chavant	(871)
Unpaid Merger-related transaction costs of Legacy Mobix	(1,633)
Merger-related transaction costs expensed	4,009
Liability-classified instruments:
Net equity impact of the Merger	(16,182)
Legacy Mobix Merger-related transaction costs [Member]
Closing disbursements:
Transaction costs	(3,747)
Chavant Merger-related transaction costs [Member]
Closing disbursements:
Transaction costs	(2,219)
Net cash proceeds from the Merger at Closing	$ 15,048
Chavant public shares, net of redemptions [Member]
Schedule of Condensed Consolidated Financial Statements [Line Items]
Total number of Class A common shares issued in the Merger (in Shares)	111,005
Chavant founder shares, net of shares forfeited [Member]
Schedule of Condensed Consolidated Financial Statements [Line Items]
Total number of Class A common shares issued in the Merger (in Shares)	1,341,369
PIPE investors’ shares [Member]
Schedule of Condensed Consolidated Financial Statements [Line Items]
Total number of Class A common shares issued in the Merger (in Shares)	1,975,000
Settlement of PIPE warrant [Member]
Schedule of Condensed Consolidated Financial Statements [Line Items]
Total number of Class A common shares issued in the Merger (in Shares)	199,800
Sponsor PIPE subscription [Member]
Schedule of Condensed Consolidated Financial Statements [Line Items]
Total number of Class A common shares issued in the Merger (in Shares)	199,737
Settlement of Sponsor Warrant [Member]
Schedule of Condensed Consolidated Financial Statements [Line Items]
Total number of Class A common shares issued in the Merger (in Shares)	272,182
Settlement of warrant to non-redeeming shareholder [Member]
Schedule of Condensed Consolidated Financial Statements [Line Items]
Total number of Class A common shares issued in the Merger (in Shares)	202,489
Amendment to Business Combination Marketing Agreement [Member]
Schedule of Condensed Consolidated Financial Statements [Line Items]
Total number of Class A common shares issued in the Merger (in Shares)	280,000
Total Chavant Shares Outstanding Immediately Prior to the Merger [Member]
Schedule of Condensed Consolidated Financial Statements [Line Items]
Total number of Class A common shares issued in the Merger (in Shares)	4,581,582
Legacy Mobix rollover shares [Member]
Schedule of Condensed Consolidated Financial Statements [Line Items]
Total number of Class A common shares issued in the Merger (in Shares)	18,139,258
Conversion of Legacy Mobix convertible notes [Member]
Schedule of Condensed Consolidated Financial Statements [Line Items]
Total number of Class A common shares issued in the Merger (in Shares)	30,045
Conversion of Legacy Mobix SAFEs [Member]
Schedule of Condensed Consolidated Financial Statements [Line Items]
Total number of Class A common shares issued in the Merger (in Shares)	150,953
Common Stock [Member] | Class A Common Stock [Member]
Schedule of Condensed Consolidated Financial Statements [Line Items]
Total number of Class A common shares issued in the Merger (in Shares)	22,901,838
Fair value of earnout liability [Member]
Liability-classified instruments:
Fair value of earnout liability	$ (33,559)
Fair Value of PIPE Make-Whole Liability [Member]
Liability-classified instruments:
Fair value of earnout liability	(2,071)
Fair value of Private Warrants [Member]
Liability-classified instruments:
Fair value of earnout liability	$ (150)

Warrants (Details)

Warrants (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended			6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2024	Mar. 31, 2023
Warrants [Line Items]
Warrants (in Shares)	400,000			400,000
Price per share	$ 3			$ 3
Percentage of gross proceeds				60%
Volume weighted average price				$ 9.2
Adjustment of exercise price of warrants based on market value and newly issued price percentage				180%
Redemption trigger price				$ 18
Warrant price adjustment (in Dollars)	$ (661)			$ (661)
Recognized liability (in Dollars)	150			150
Estimated fair value (in Dollars)	630			630
Non-cash losses (in Dollars)	420			480
Changes in fair value (in Dollars)	$ 526			526
Cash proceeds (in Dollars)				3,286	$ 6,897
Fair value of selling and administrative expenses (in Dollars)				$ 1,598
Public Warrants [Member]
Warrants [Line Items]
Warrants (in Shares)	6,000,000			6,000,000
Price per share	$ 0.01			$ 0.01
Private Warrant [Member]
Warrants [Line Items]
Warrants (in Shares)	3,400,000			3,400,000
Sponsor [Member]
Warrants [Line Items]
Warrants (in Shares)	400,000			400,000
Warrants [Member]
Warrants [Line Items]
Warrants (in Shares)			300,000
Price per share	$ 0.01			$ 0.01
Adjustment of exercise price of warrants based on market value and newly issued price percentage				115%
Common Stock [Member]
Warrants [Line Items]
Price per share	$ 0.01			$ 0.01
Common Stock [Member] | Warrants [Member]
Warrants [Line Items]
Price per share		$ 3			$ 3
Legacy Mobix [Member]
Warrants [Line Items]
Warrants (in Shares)	51,020			51,020
Price per share	$ 0.01			$ 0.01
PIPE Subscription Agreement [Member]
Warrants [Line Items]
Price per share	0.01			0.01
PIPE Subscription Agreement [Member] | Warrants [Member]
Warrants [Line Items]
Cash proceeds (in Dollars)			$ 900
PIPE Subscription Agreement [Member] | Maximum [Member]
Warrants [Line Items]
Price per share	11.5			11.5
Redemption trigger price				18
PIPE Subscription Agreement [Member] | Minimum [Member]
Warrants [Line Items]
Price per share	$ 5.79			5.79
Redemption trigger price				$ 9.06
Investor [Member]
Warrants [Line Items]
Warrants (in Shares)	27,413			27,413
Price per share	$ 0.01			$ 0.01
Legacy Mobix [Member]
Warrants [Line Items]
Price per share	0.01			$ 0.01
Liability fair value of warrants (in Dollars)				$ 206
Class A Common Stock [Member]
Warrants [Line Items]
Warrants (in Shares)		300,000			300,000
Price per share	$ 18			$ 18
Warrant price adjustment (in Dollars)	$ (608)			$ (600)
Issue warrants (in Shares)				103,000
Class A Common Stock [Member] | Public Warrants [Member]
Warrants [Line Items]
Price per share	$ 11.5			$ 11.5
Class A Common Stock [Member] | Warrants [Member]
Warrants [Line Items]
Warrants (in Shares)	130,000			130,000
Price per share	$ 0.01			$ 0.01
Legacy Mobix Warrants [Member]
Warrants [Line Items]
Warrants (in Shares)	373,031			373,031
Legacy Mobix Warrants [Member] | Class A Common Stock [Member]
Warrants [Line Items]
Warrants (in Shares)	369,671			369,671

Acquisition of EMI Solutions,_3

Acquisition of EMI Solutions, Inc. (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended
	Mar. 31, 2024	Sep. 30, 2023
Acquisition of EMI Solutions, Inc. [Line Items]
Cash	$ 2,200
Consideration paid	155
Cash portion	2,993	$ 89
Cash consideration	$ 174
Repurchase shares of common stock (in Shares)	964,912
Percentage of expected volatility	55%
Percentage of dividend yield
Percentage of risk-free interest rate	4.50%
Permanent equity, carrying value	$ 8,856
Legacy Mobix [Member]
Acquisition of EMI Solutions, Inc. [Line Items]
Price per share (in Dollars per share)	$ 6,840
Common stock value	$ 8,856
Business Acquisition [Member]
Acquisition of EMI Solutions, Inc. [Line Items]
Estimated fair value	8,856
Acquisition payable	1,000
EMI Solutions Inc [Member]
Acquisition of EMI Solutions, Inc. [Line Items]
Cash portion	1,045
Revenue	997
Comprehensive loss	$ 454
Common Stock [Member]
Acquisition of EMI Solutions, Inc. [Line Items]
Consideration acquisition shares (in Shares)	964,912
Repurchase shares of common stock (in Shares)	964,912

Acquisition of EMI Solutions,_4

Acquisition of EMI Solutions, Inc. (Details) - Schedule of Purchase Consideration and Allocation - EMI [Member] $ in Thousands	6 Months Ended
	Mar. 31, 2024 USD ($)
Purchase consideration:
Contingently redeemable common stock issued to seller	$ 8,856
Cash consideration (at present value)	2,041
Total purchase consideration	10,897
Allocation:
Cash	45
Accounts receivable	387
Inventory	155
Other current assets	7
Property and equipment	107
Other assets	30
Goodwill	5,542
Accounts payable	(227)
Accrued expenses	(263)
Deferred tax liability	(1,386)
Total allocation	10,897
Intangible asset – customer relationships [Member]
Allocation:
Intangible asset	6,100
Intangible asset – backlog [Member]
Allocation:
Intangible asset	300
Intangible asset – trade name [Member]
Allocation:
Intangible asset	$ 100

Acquisition of EMI Solutions,_5

Acquisition of EMI Solutions, Inc. (Details) - Schedule of Unaudited Pro Forma Revenues and Net Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Schedule of Unaudited Pro Forma Revenues and Net Loss [Abstract]
Revenues	$ 1,145	$ 678	$ 2,197	$ 2,015
Net loss	$ (1,753)	$ (13,129)	$ (733)	$ (22,692)

Inventory (Details) - Schedule

Inventory (Details) - Schedule of Inventory - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Schedule of Inventory [Abstract]
Raw materials	$ 183	$ 265
Finished goods	178	54
Total inventory	$ 361	$ 319

Property and Equipment, Net (De

Property and Equipment, Net (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Property and Equipment, Net [Abstract]
Depreciation expense	$ 117	$ 112	$ 230	$ 225

Property and Equipment, Net (_2

Property and Equipment, Net (Details) - Schedule of Property and Equipment - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023	Mar. 30, 2023
Schedule of Property and Equipment [Line Items]
Property and equipment gross	$ 3,020		$ 2,893
Less: Accumulated depreciation	(1,257)		(1,034)
Property and equipment, net	1,763	$ 1,859	1,859
Equipment and furniture [Member]
Schedule of Property and Equipment [Line Items]
Property and equipment gross	$ 924		858
Laboratory equipment [Member]
Schedule of Property and Equipment [Line Items]
Property and equipment estimated useful life	5 years
Property and equipment gross	$ 621		601
Leasehold improvements [Member]
Schedule of Property and Equipment [Line Items]
Property and equipment gross	$ 891		850
Property and equipment estimated useful life	Shorter of estimated useful life or remaining lease term
Construction in progress [Member]
Schedule of Property and Equipment [Line Items]
Property and equipment gross	$ 584		$ 584
Minimum [Member] | Equipment and furniture [Member]
Schedule of Property and Equipment [Line Items]
Property and equipment estimated useful life	5 years
Maximum [Member] | Equipment and furniture [Member]
Schedule of Property and Equipment [Line Items]
Property and equipment estimated useful life	7 years

Intangible Assets, Net (Details

Intangible Assets, Net (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Intangible Assets, Net [Line Items]
Amortization of intangible assets	$ 399	$ 210	$ 636	$ 421
Developed Technology Rights [Member]
Intangible Assets, Net [Line Items]
weighted-average remaining lives of intangible assets			5 years 10 months 24 days
Customer Relationships [Member]
Intangible Assets, Net [Line Items]
weighted-average remaining lives of intangible assets			14 years 6 months
Trade Names [Member]
Intangible Assets, Net [Line Items]
weighted-average remaining lives of intangible assets			1 year 8 months 12 days
Backlog [Member]
Intangible Assets, Net [Line Items]
weighted-average remaining lives of intangible assets			9 years

Intangible Assets, Net (Detai_2

Intangible Assets, Net (Details) - Schedule of Intangible Assets - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Schedule of Intangible Assets [Line Items]
Gross	$ 14,089	$ 7,589
Accumulated Amortization	(2,938)	(2,302)
Net	11,151	5,287
Developed technology [Member]
Schedule of Intangible Assets [Line Items]
Gross	7,289	7,289
Accumulated Amortization	(2,644)	(2,238)
Net	4,645	5,051
Customer relationships [Member]
Schedule of Intangible Assets [Line Items]
Gross	6,400	300
Accumulated Amortization	(195)	(64)
Net	$ 6,205	236
Trade names [Member]
Schedule of Intangible Assets [Line Items]
Estimated Useful Life (years)	2 years
Gross	$ 100
Accumulated Amortization	(14)
Net	$ 86
Backlog [Member]
Schedule of Intangible Assets [Line Items]
Estimated Useful Life (years)	1 year
Gross	$ 300
Accumulated Amortization	(85)
Net	$ 215
Minimum [Member] | Developed technology [Member]
Schedule of Intangible Assets [Line Items]
Estimated Useful Life (years)	7 years
Minimum [Member] | Customer relationships [Member]
Schedule of Intangible Assets [Line Items]
Estimated Useful Life (years)	10 years
Maximum [Member] | Developed technology [Member]
Schedule of Intangible Assets [Line Items]
Estimated Useful Life (years)	10 years
Maximum [Member] | Customer relationships [Member]
Schedule of Intangible Assets [Line Items]
Estimated Useful Life (years)	15 years

Intangible Assets, Net (Detai_3

Intangible Assets, Net (Details) - Schedule of Estimated Future Amortization Expense for Intangible Assets $ in Thousands	Mar. 31, 2024 USD ($)
Schedule Of Estimated Future Amortization Expense For Intangible Assets [Abstract]
2024 (remaining six months)	$ 799
2025	1,361
2026	1,258
2027	1,247
2028	1,213
Thereafter	5,273
Total	$ 11,151

Goodwill (Details) - Schedule o

Goodwill (Details) - Schedule of Goodwill $ in Thousands	6 Months Ended
	Mar. 31, 2024 USD ($)
Schedule of Goodwill [Abstract]
Balance at September 30, 2023	$ 5,217
Acquisition of EMI	5,542
Balance at March 31, 2024	$ 10,759

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities (Details) - Schedule of Accrued Expenses and Other Current Liabilities - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Schedule of Accrued Expenses and Other Current Liabilities [Abstract]
Accrued compensation and benefits	$ 1,765	$ 2,841
Liability-classified warrants	206
Accrued professional fees	706	273
Accrued interest	132	304
Deferred revenue	43	138
Committed equity facility fees	1,575
Unpaid Merger-related transaction costs	1,240
Other	1,369	963
Total accrued expenses and other current liabilities	$ 7,036	$ 4,519

Debt (Details)

Debt (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	6 Months Ended
	Sep. 30, 2023	Mar. 31, 2024	Mar. 31, 2023
Debt [Line Items]
Exercise price per share (in Dollars per share)		$ 3
Proceeds allocated to warrants		$ 79
Expected volatility rate		55.60%
Expected dividend yield
Risk-free interest rate		5.30%
Aggregate principal amount	$ 531
Warrant to purchase additional shares (in Shares)			15,000
Warrants to purchase aggregate shares (in Shares)			35,464
Remaining principal balance	1,286	$ 400
Principal balance			$ 106
Original purchase amount		1,000
Carrying amount of SAFE	1,512
Common stock at exercise prices (in Dollars per share)		$ 0.01
Warrant [Member]
Debt [Line Items]
Warrant to purchase (in Shares)		47,020
Exercise price per share (in Dollars per share)		$ 0.01
Warrant to purchase shares (in Shares)		28,000
Warrant to purchase additional shares (in Shares)		25,000
Two Promissory Note [Member]
Debt [Line Items]
Principal amount		$ 250
Notes Payable [Member]
Debt [Line Items]
Principal amount		2,763
Repaid principal amount		$ 100	350
Warrants contractual term		12 months
Contractual term		12 years
Fair value		$ 10	50
Five Promissory Notes [Member]
Debt [Line Items]
Principal amount			$ 1,100
Promissory Notes [Member]
Debt [Line Items]
Principal amount		586
Exercise price per share (in Dollars per share)			$ 0.01
Remaining principal balance		$ 400
Bear interest		7%
Promissory Notes-Related parties [Member]
Debt [Line Items]
Promissory notes percentage		7%
SAFEs [Member]
Debt [Line Items]
Carrying amount of SAFE		$ 1,512
Convertible Notes [Member]
Debt [Line Items]
Bore interest percentage		16%
Conversion price per share (in Dollars per share)		$ 6.84
Carrying amount of equity		$ 206
Minimum [Member]
Debt [Line Items]
Percentage of interest at rates		6%
Expected dividend yield		0%	0%
Contractual term		4 years 6 months	5 years
Maximum [Member]
Debt [Line Items]
Percentage of interest at rates		76%
Expected dividend yield		0%	0%
Contractual term		5 years 3 months 18 days	5 years 9 months 18 days
Common Stock [Member]
Debt [Line Items]
Exercise price per share (in Dollars per share)		$ 0.01
Warrants to purchase aggregate shares (in Shares)		103,000
Common Stock [Member] | Warrant [Member]
Debt [Line Items]
Exercise price per share (in Dollars per share)			$ 3
Related Parties [Member]
Debt [Line Items]
Remaining principal balance	444
Related Parties [Member] | Notes Payable [Member]
Debt [Line Items]
Principal amount	$ 444
Related Parties [Member] | Promissory Notes [Member]
Debt [Line Items]
Bear interest		7%
Related Parties [Member] | Promissory Notes-Related parties [Member]
Debt [Line Items]
Bear interest	7%	7%
Convertible Notes [Member] | Notes Payable [Member]
Debt [Line Items]
Principal amount		$ 200
Investor [Member] | Warrant [Member]
Debt [Line Items]
Warrants to purchase aggregate shares (in Shares)		4,000
Director [Member] | Two Promissory Note [Member]
Debt [Line Items]
Principal amount		$ 150
Director [Member] | Notes Payable [Member]
Debt [Line Items]
Principal amount		$ 4
Class A Common Stock [Member]
Debt [Line Items]
Exercise price per share (in Dollars per share)		$ 18
Warrants to purchase aggregate shares (in Shares)			165,000
Converted shares (in Shares)		150,953
Class A Common Stock [Member] | Warrant [Member]
Debt [Line Items]
Exercise price per share (in Dollars per share)		$ 0.01
Class A Common Stock [Member] | Convertible Notes [Member]
Debt [Line Items]
Converted shares (in Shares)		30,045

Debt (Details) - Schedule of De

Debt (Details) - Schedule of Debt - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Schedule of Debt [Line Items]
Notes payable	$ 400	$ 1,286
Notes payable – related parties	400	1,286
SAFEs		1,512
Total debt	3,163	6,591
Less: Amounts classified as current	(3,163)	(6,591)
Noncurrent portion
Related Party [Member]
Schedule of Debt [Line Items]
Notes payable		444
7% promissory notes – related parties	2,763	3,349
Notes payable – related parties		$ 444

Debt (Details) - Schedule of _2

Debt (Details) - Schedule of Debt (Parentheticals)	Mar. 31, 2024	Sep. 30, 2023
Promissory notes – related parties [Member] | Related Party [Member]
Schedule of Debt [Line Items]
Percentage of promissory notes	7%	7%

Fair Value Measurements (Detail

Fair Value Measurements (Details)	Mar. 31, 2024	Sep. 30, 2023
Promissory Notes [Member]
Fair Value Measurements [Line Items]
Percentage of promissory notes	7%	7%

Fair Value Measurements (Deta_2

Fair Value Measurements (Details) - Schedule of Liabilities Measured at Fair Value on a Recurring Basis - Fair Value, Recurring [Member] $ in Thousands	6 Months Ended
	Mar. 31, 2024 USD ($)
Schedule of Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Total	$ 6,096
Level 1 [Member]
Schedule of Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Total
Level 2 [Member]
Schedule of Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Total
Level 3 [Member]
Schedule of Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Total	6,096
Earnout liability [Member]
Schedule of Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Total	3,621
Earnout liability [Member] | Level 1 [Member]
Schedule of Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Total
Earnout liability [Member] | Level 2 [Member]
Schedule of Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Total
Earnout liability [Member] | Level 3 [Member]
Schedule of Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Total	3,621
PIPE make-whole liability [Member]
Schedule of Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Total	1,639
PIPE make-whole liability [Member] | Level 1 [Member]
Schedule of Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Total
PIPE make-whole liability [Member] | Level 2 [Member]
Schedule of Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Total
PIPE make-whole liability [Member] | Level 3 [Member]
Schedule of Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Total	1,639
Private Warrants and other warrants [Member]
Schedule of Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Total	836
Private Warrants and other warrants [Member] | Level 1 [Member]
Schedule of Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Total
Private Warrants and other warrants [Member] | Level 2 [Member]
Schedule of Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Total
Private Warrants and other warrants [Member] | Level 3 [Member]
Schedule of Liabilities Measured at Fair Value on a Recurring Basis [Line Items]
Total	$ 836

Fair Value Measurements (Deta_3

Fair Value Measurements (Details) - Schedule of Fair Value on a Recurring Basis Using Level 3 Inputs - USD ($) $ in Thousands	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Earnout Liability [Member]
Schedule of Fair Value on a Recurring Basis Using Level 3 Inputs [Line Items]
Balance beginning
Liabilities recognized	33,559
Conversion to Class A Common Stock in the Merger
Change in fair value included in net loss	(29,938)
Balance ending	3,621
PIPE Make-Whole Liability [Member]
Schedule of Fair Value on a Recurring Basis Using Level 3 Inputs [Line Items]
Balance beginning
Liabilities recognized	2,071
Conversion to Class A Common Stock in the Merger
Change in fair value included in net loss	(432)
Balance ending	1,639
Private Warrants and Other Warrants [Member]
Schedule of Fair Value on a Recurring Basis Using Level 3 Inputs [Line Items]
Balance beginning
Liabilities recognized	882
Conversion to Class A Common Stock in the Merger
Change in fair value included in net loss	(46)
Balance ending	836
SAFEs [Member]
Schedule of Fair Value on a Recurring Basis Using Level 3 Inputs [Line Items]
Balance beginning	1,512
Liabilities recognized
Conversion to Class A Common Stock in the Merger	(1,522)
Change in fair value included in net loss	10
Balance ending
SAFEs [Member]
Schedule of Fair Value on a Recurring Basis Using Level 3 Inputs [Line Items]
Balance beginning		$ 1,983
Change in fair value included in net loss		558
Balance ending		$ 2,541

Fair Value Measurements (Deta_4

Fair Value Measurements (Details) - Schedule of Assumptions Used in Estimating the Fair Value - $ / shares	3 Months Ended	6 Months Ended
	Dec. 21, 2023	Mar. 31, 2024
Earnout Liability [Member]
Schedule of Assumptions Used in Estimating the Fair Value [Line Items]
Stock price (in Dollars per share)	$ 10.66	$ 2.01
Expected volatility	50%	60%
Risk-free rate	3.90%	4.10%
Contractual term	8 years	7 years 8 months 12 days
PIPE Make-Whole Liability [Member]
Schedule of Assumptions Used in Estimating the Fair Value [Line Items]
Stock price (in Dollars per share)	$ 10.17	$ 1.56
Expected volatility	49%	51%
Risk-free rate	5.40%	5.40%
Contractual term	4 years	3 years

Leases (Details)

Leases (Details) $ in Thousands	6 Months Ended
	Mar. 31, 2024 USD ($) m²	Mar. 31, 2023 USD ($)
Leases [Line Items]
Remaining terms	3 years 4 months 24 days
Lease covering (in Square Meters) | m²	19,436
Lease security deposit	$ 400
Operating lease liabilities	$ 273	$ 264
Remaining lease term	3 years 4 months 24 days
Weighted average discount rate	15.60%

Leases (Details) - Schedule of

Leases (Details) - Schedule of Lease Costs - USD ($) $ in Thousands	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Schedule of Lease Costs [Abstract]
Operating lease cost	$ 200	$ 202
Short-term lease cost	46	155
Total lease cost	$ 246	$ 357

Leases (Details) - Schedule o_2

Leases (Details) - Schedule of Undiscounted Cash Flows to the Operating Lease Liabilities - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Schedule of Undiscounted Cash Flows to the Operating Lease Liabilities [Abstract]
2024 (remaining six months)	$ 275
2025	526
2026	545
2027	515
Total minimum lease payments	1,861
Less: imputed interest	(420)
Present value of future minimum lease payments	1,441
Less: current obligations under leases	(332)	$ (318)
Long-term lease obligations	$ 1,109	$ 1,280

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Thousands		6 Months Ended
	Sep. 30, 2022	Mar. 31, 2024	Mar. 31, 2023
Commitments and Contingencies [Line Items]
Unconditional purchase commitment		$615
Shares of common stock in settlement amount	$ 8,434
Common Stock [Member]
Commitments and Contingencies [Line Items]
Shares of common stock in settlement			1,233,108

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Income Taxes [Line Items]
Provision (benefit) for income taxes	$ 16	$ 1	$ 1,296	$ 32
Deferred tax liability	$ 1,386		1,386
Income tax benefit			$ 1,296

Equity (Details)

Equity (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended	6 Months Ended
	Dec. 20, 2023	Mar. 31, 2024	Mar. 31, 2024	Mar. 31, 2023	Apr. 30, 2024	Mar. 18, 2024	Sep. 30, 2023
Equity [Line Items]
Issuance of common stock	202,692
Private placement net proceeds (in Dollars)			$ 3,286
Price per share (in Dollars per share)		$ 3	$ 3
Shares issued	199,737					9,500,000
Cash commitment fee (in Dollars)		$ 1,500	$ 1,500
Cash form aggregate purchase price			30%
Legal fees (in Dollars)			$ 75
Registration rights agreement (in Dollars)			5
Other fees (in Dollars)		$ 1,575	$ 1,575
Legacy Mobix [Member]
Equity [Line Items]
Issuance of common stock				993,364
Private placement net proceeds (in Dollars)				$ 6,795
Shares of common stock			27,413
Price per share (in Dollars per share)		$ 0.01	$ 0.01
Class A Common Stock [Member]
Equity [Line Items]
Shares authorized		285,000,000	285,000,000				285,000,000
Common stock vote			one
Price per share (in Dollars per share)		$ 18	$ 18
Shares issued					9,500,000
Class B Common Stock [Member]
Equity [Line Items]
Shares authorized		5,000,000	5,000,000				5,000,000
Common stock vote			ten
Convertible preferred stock		2,254,901	2,254,901
Common Stock [Member]
Equity [Line Items]
Issuance of common stock			482,171
Preferred Stock [Member] | Legacy Mobix [Member]
Equity [Line Items]
Preferred stock par share (in Dollars per share)		$ 0.00001	$ 0.00001
Preferred Stock [Member] | Legacy Mobix [Member]
Equity [Line Items]
Shares of preferred stock		10,000,000	10,000,000

Equity (Details) - Schedule of

Equity (Details) - Schedule of Common Stock Available for Issuance - shares	Mar. 31, 2024	Sep. 30, 2023
Equity [Line Items]
Class A Common Stock outstanding	23,600,558
Reserve for conversion of Class B Common Stock	2,254,901
Reserve for exercise of the Public Warrants and Private Warrants	9,000,000
Reserve for exercise of other common stock warrants outstanding or issuable	3,320,020
Shares issuable under PIPE make-whole provision	1,052,030
Reserve for earnout shares	3,500,000
Stock options and RSUs outstanding	8,601,088
Awards available for grant under 2023 Equity Incentive Plan	2,290,183
Awards available for grant under 2023 Employee Stock Purchase Plan	2,290,183
Common stock available for issuance	230,522,285
Class A Common Stock [Member]
Equity [Line Items]
Authorized number of shares of Class A Common Stock	285,000,000	285,000,000
Class A Common Stock outstanding	23,600,558
Reserve for conversion of Class B Common Stock	2,254,901
Employee Stock Purchase Plan [Member]
Equity [Line Items]
Awards available for grant under 2023 Equity Incentive Plan	858,935
Awards available for grant under 2023 Employee Stock Purchase Plan	858,935

Equity Incentive Plans (Details

Equity Incentive Plans (Details) - USD ($) $ / shares in Units, $ in Thousands			1 Months Ended	3 Months Ended	6 Months Ended
	May 31, 2023	Mar. 31, 2023	Nov. 30, 2022	Mar. 31, 2024	Mar. 31, 2024	Mar. 31, 2023
Equity Incentive Plans [Line Items]
Shares of common stock				2,290,183	2,290,183
Fair market value percentage					85%
Restrticed stock units shares	10,000,000	10,000,000	10,000,000		1,000,000
Forfeited shares						670,000
Common stock warrants				400,000	400,000
Stock based compensation expense (in Dollars)				$ 2,242		$ 3,706
Unrecognized compensation expense (in Dollars)					$ 1,911
Weighted-average period					2 years
Aggregate intrinsic value of stock options outstanding (in Dollars)				3,626	$ 3,626
Stock options exercisable (in Dollars)				$ 3,626	3,626
Total intrinsic value (in Dollars)					1,938	0
Fair value of options vested (in Dollars)					$ 1,221	$ 1,887
Weighted-average grant date fair value of options (in Dollars per share)					$ 3.5	$ 3.58
Restricted Stock Units (RSUs) [Member]
Equity Incentive Plans [Line Items]
Restrticed stock units shares			5,000,000
Forfeited shares			10,000,000
Common stock warrants			1,000,000
Stock based compensation expense (in Dollars)					$ 11,846
Unrecognized compensation expense (in Dollars)					$ 33,946
Weighted-average period					3 years 9 months 18 days
Stock Options [Member]
Equity Incentive Plans [Line Items]
Stock option shares					474,313
Class A Common Stock [Member]
Equity Incentive Plans [Line Items]
Common stock warrants		300,000				300,000
Class A Common Stock [Member] | Stock Options [Member]
Equity Incentive Plans [Line Items]
Stock option shares					198,115
2023 Equity Incentive Plan [Member]
Equity Incentive Plans [Line Items]
Shares of common stock				2,290,183	2,290,183
2023 Employee Stock Purchase Plan [Member]
Equity Incentive Plans [Line Items]
Shares of common stock				858,935	858,935

Equity Incentive Plans (Detai_2

Equity Incentive Plans (Details) - Summary of Activity in the Company's RSUs - Restricted Stock Units (RSUs) [Member]	6 Months Ended
	Mar. 31, 2024 $ / shares shares
Summary of Activity in the Company's RSUs [Line Items]
Number of units, Outstanding | shares	209,494
Weighted-Average Grant Date Fair Value per Unit, Outstanding | $ / shares	$ 6.84
Number of units, Performance-based RSUs | shares	3,999,999
Weighted-Average Grant Date Fair Value per Unit, Performance-based RSUs | $ / shares	$ 8.65
Number of units, Vested | shares	(130,934)
Weighted-Average Grant Date Fair Value per Unit, Vested | $ / shares	$ 6.84
Number of units, Outstanding | shares	4,078,559
Weighted-Average Grant Date Fair Value per Unit, Outstanding | $ / shares	$ 8.61

Equity Incentive Plans (Detai_3

Equity Incentive Plans (Details) - Schedule of Stock Option Activity - Stock option activity [Member] - $ / shares	6 Months Ended
	Mar. 31, 2024
Schedule of Stock Option Activity [Line Items]
Number of Options, Outstanding	5,905,684
Weighted-Average Exercise Price per Share, Outstanding	$ 4.28
Number of Options, Outstanding	4,522,529
Weighted-Average Exercise Price per Share, Outstanding	$ 3.66
Weighted-Average Remaining Contractual Term (years), Outstanding	6 years 3 months 18 days
Number of Options, Exercisable	4,041,704
Weighted-Average Exercise Price per Share, Exercisable	$ 3.29
Weighted-Average Remaining Contractual Term (years), Exercisable	6 years 1 month 6 days
Number of Options, Granted	32,200
Weighted-Average Exercise Price per Share, Granted	$ 6.84
Number of Options, Exercised	(474,313)
Weighted-Average Exercise Price per Share, Exercised	$ 5.91
Number of Options, Forfeited	(941,042)
Weighted-Average Exercise Price per Share, Forfeited	$ 6.53

Equity Incentive Plans (Detai_4

Equity Incentive Plans (Details) - Schedule of Weighted-Average Grant Date Fair Value of Options Granted	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Low [Member]
Schedule of Weighted-Average Grant Date Fair Value of Options Granted [Line Items]
Expected volatility	54.80%	52.40%
Expected dividend yield	0%	0%
Risk-free interest rate	3.90%	3.60%
Expected term (years)	4 years 6 months	5 years
High [Member]
Schedule of Weighted-Average Grant Date Fair Value of Options Granted [Line Items]
Expected volatility	55.60%	53.60%
Expected dividend yield	0%	0%
Risk-free interest rate	4.40%	4.20%
Expected term (years)	5 years 3 months 18 days	5 years 9 months 18 days

Equity Incentive Plans (Detai_5

Equity Incentive Plans (Details) - Schedule of Consolidated Statements of Operations and Comprehensive Loss Include Stock-Based Compensation Expense - Stock Option [Member] - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Schedule of Consolidated Statements of Operations and Comprehensive Loss Include Stock-Based Compensation Expense [Line Items]
Cost of revenue		$ 11		$ 22
Research and development	274	541	775	1,083
Selling, general and administrative	1,167	5,227	13,371	8,530
Total stock-based compensation expense	$ 1,441	$ 5,779	$ 14,146	$ 9,635

Net Loss Per Share (Details) -

Net Loss Per Share (Details) - Schedule of Net Income (Loss) Per Share Per Common Share of Basic and Diluted - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Class A Common Stock [Member]
Numerator:
Allocation of net loss	$ (1,612)		$ (742)
Deemed dividend from warrant price adjustment	(608)		(600)
Net loss available to common stockholders	$ (2,220)		$ (1,342)
Denominator:
Weighted-average shares outstanding (in Shares)	25,791,094		22,004,134
Basic net loss per share (in Dollars per share)	$ (0.09)		$ (0.06)
Numerator:
Net loss available to common stockholders	$ (2,220)		$ (1,342)
Change in fair value of PIPE make-whole liability	(3,068)		(392)
Change in fair value of liability-classified warrants	(483)		(476)
Reallocation of net loss as a result of conversion of Class B to Class A Common Stock	(504)		(226)
Reallocation of net loss
Allocation of net loss	$ (6,275)		$ (2,436)
Denominator:
Number of shares used in basic earnings per share calculation (in Shares)	25,791,094		22,004,134
Shares issuable in satisfaction of PIPE make-whole liability (in Shares)	1,052,030		580,628
Shares issuable under liability-classified warrants	$ 101,228		$ 74,906
Conversion of Class B to Class A Common Stock (in Shares)	2,254,901		2,254,901
Number of shares used in per share computation (in Shares)	29,199,253		24,914,569
Diluted net loss per share (in Dollars per share)	$ (0.21)		$ (0.1)
Class B Common Stock [Member]
Numerator:
Allocation of net loss	$ (141)		$ (76)
Deemed dividend from warrant price adjustment	(53)		(61)
Net loss available to common stockholders	$ (194)		$ (137)
Denominator:
Weighted-average shares outstanding (in Shares)	2,254,901		2,254,901
Basic net loss per share (in Dollars per share)	$ (0.09)		$ (0.06)
Numerator:
Net loss available to common stockholders	$ (194)		$ (137)
Change in fair value of PIPE make-whole liability	(268)		(40)
Change in fair value of liability-classified warrants	(42)		(49)
Reallocation of net loss as a result of conversion of Class B to Class A Common Stock
Reallocation of net loss	19		6
Allocation of net loss	$ (485)		$ (220)
Denominator:
Number of shares used in basic earnings per share calculation (in Shares)	2,254,901		2,254,901
Shares issuable in satisfaction of PIPE make-whole liability (in Shares)
Shares issuable under liability-classified warrants
Conversion of Class B to Class A Common Stock (in Shares)
Number of shares used in per share computation (in Shares)	2,254,901		2,254,901
Diluted net loss per share (in Dollars per share)	$ (0.21)		$ (0.1)
Common Stock [Member]
Numerator:
Allocation of net loss		$ (13,142)		$ (22,532)
Deemed dividend from warrant price adjustment
Net loss available to common stockholders		$ (13,142)		$ (22,532)
Denominator:
Weighted-average shares outstanding (in Shares)		14,025,304		13,189,879
Basic net loss per share (in Dollars per share)		$ (0.94)		$ (1.71)
Numerator:
Net loss available to common stockholders		$ (13,142)		$ (22,532)
Change in fair value of PIPE make-whole liability
Change in fair value of liability-classified warrants
Reallocation of net loss as a result of conversion of Class B to Class A Common Stock
Reallocation of net loss
Allocation of net loss		$ (13,142)		$ (22,532)
Denominator:
Number of shares used in basic earnings per share calculation (in Shares)		14,025,304		13,189,879
Shares issuable in satisfaction of PIPE make-whole liability (in Shares)
Shares issuable under liability-classified warrants
Conversion of Class B to Class A Common Stock (in Shares)
Number of shares used in per share computation (in Shares)		14,025,304		13,189,879
Diluted net loss per share (in Dollars per share)		$ (0.94)		$ (1.71)

Net Loss Per Share (Details) _2

Net Loss Per Share (Details) - Schedule of Dilutive Securities not Included in Net Income (Loss) Per Share Common Share - USD ($)	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Schedule of Dilutive Securities not Included in Net Income (Loss) Per Share Common Share [Abstract]
Public Warrants and Private Warrants	9,000,000
Earnout shares	3,500,000
RSUs	4,078,559	10,984,241
Stock options	4,522,529	6,400,758
Convertible preferred stock (on an as-converted basis)		2,254,901
Common stock warrants		400,000
Convertible notes (in Dollars)		$ 131,072,000
Total	21,101,088	20,170,972

Concentrations (Details)

Concentrations (Details) - Customer Concentration Risk [Member] - Revenue Benchmark [Member]	1 Months Ended	3 Months Ended		6 Months Ended
	Sep. 30, 2023	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
One Customer [Member]
Concentrations [Line Items]
Risk percentage		26%			82%
Two Customer [Member]
Concentrations [Line Items]
Risk percentage	97%		100%	48%
Three customers [Member]
Concentrations [Line Items]
Risk percentage				48%
Other Customer [Member]
Concentrations [Line Items]
Risk percentage					10%

Geographical Information (Detai

Geographical Information (Details) - Schedule of Company’s Revenue by Geographic Region - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		15 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024
Schedule of Company’s Revenue by Geographic Region [Line Items]
Revenue	$ 1,145	$ 32	$ 1,430	$ 711	$ 1,145
United States [Member]
Schedule of Company’s Revenue by Geographic Region [Line Items]
Revenue		32	1,248	298	980
Czech Republic [Member]
Schedule of Company’s Revenue by Geographic Region [Line Items]
Revenue			17	185
Thailand [Member]
Schedule of Company’s Revenue by Geographic Region [Line Items]
Revenue				225
Other [Member]
Schedule of Company’s Revenue by Geographic Region [Line Items]
Revenue			$ 165	$ 3	$ 165

Subsequent Events (Details)

Subsequent Events (Details) - USD ($) $ in Thousands	6 Months Ended
	Mar. 31, 2024	Apr. 15, 2025	Nov. 15, 2024
Subsequent Events [Line Items]
Aggregate cash	$ 2,000
Sellers aggregate amount	200
Earn-out payments	$ 8,000
Subsequent Event [Member]
Subsequent Events [Line Items]
Payable amount		$ 800
Class A Common Stock [Member] | Agreement to Acquire RaGE Systems, Inc. [Member]
Subsequent Events [Line Items]
Acquisition shares (in Shares)	3,214,045
Forecast [Member]
Subsequent Events [Line Items]
Aggregate consideration	$ 12,000
Sellers aggregate amount			$ 1,000